torbey unm cv 10.2 unm cv 10_2_19 (1).pdf · 07/2006 – 06/2009 associate director, neurosciences...

44
CURRICULUM VITAE Michel T. Torbey, M.D., M.P.H., F.A.H.A, F.C.C.M., F.N.C.S, F.A.N.A Professor and Chairman Departments of Neurology HOME ADDRESS: 11735 Sky Valley Way NE Albuquerque, NM 87111 Mobile: (414) 791-6701 Email: [email protected] OFFICE ADDRESS: University of New Mexico Department of Neurology 2211 Lomas Blvd, NE Neurology-2ACC Albuquerque, NM 87106 E-mail: [email protected] PART I: BACKGROUND EDUCATION: 09/1986 – 08/1989 BS, American University of Beirut, Beirut, Lebanon 09/1989 – 06/1993 MD, American University of Beirut, Beirut, Lebanon 07/1997 – 05/1999 MPH, University of Massachusetts, Amherst, MA POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: 07/1993 – 06/1994 Resident in Surgery, American University of Beirut Medical Center, Beirut, Lebanon 07/1995 – 06/1996 Resident in Internal Medicine, Good Samaritan Hospital (Johns Hopkins System), Baltimore, MD 07/1996 – 06/1999 Resident in Neurology, University of Massachusetts Medical School, Worcester, MA 07/1999 – 06/2001 Neuroscience Critical Care Fellow, Johns Hopkins University School of Medicine, Baltimore, MD 07/2000 – 06/2001 American Heart Association Fellow, Johns Hopkins University School of Medicine, Baltimore, MD

Upload: others

Post on 26-Jun-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

CURRICULUM VITAE

Michel T. Torbey, M.D., M.P.H., F.A.H.A, F.C.C.M., F.N.C.S, F.A.N.A Professor and Chairman

Departments of Neurology

HOME ADDRESS: 11735 Sky Valley Way NE

Albuquerque, NM 87111 Mobile: (414) 791-6701 Email: [email protected]

OFFICE ADDRESS: University of New Mexico

Department of Neurology 2211 Lomas Blvd, NE Neurology-2ACC Albuquerque, NM 87106 E-mail: [email protected]

PART I: BACKGROUND EDUCATION:

09/1986 – 08/1989 BS, American University of Beirut, Beirut, Lebanon 09/1989 – 06/1993 MD, American University of Beirut, Beirut, Lebanon 07/1997 – 05/1999 MPH, University of Massachusetts, Amherst, MA

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:

07/1993 – 06/1994 Resident in Surgery, American University of Beirut Medical Center, Beirut, Lebanon

07/1995 – 06/1996 Resident in Internal Medicine, Good Samaritan Hospital (Johns Hopkins

System), Baltimore, MD 07/1996 – 06/1999 Resident in Neurology, University of Massachusetts Medical School,

Worcester, MA 07/1999 – 06/2001 Neuroscience Critical Care Fellow, Johns Hopkins University School of

Medicine, Baltimore, MD 07/2000 – 06/2001 American Heart Association Fellow, Johns Hopkins University School of

Medicine, Baltimore, MD

Page 2: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

2

SPECIALTY BOARDS AND CERTIFICATION:

Board Certified Issue Date Expiration American Board of Psychiatry and Neurology 09/2005 12/2025 Neurocritical Care 12/2007 12/2027 Vascular Neurology 05/2008 05/2028

Certificates Issued By Issue Date Expiration ECFMG ECFMG 09/1994 NA Neurosonology American Society of Neuroimaging 03/2003 NA

Licensure Issue Date Expiration Massachusetts License 10/22/1997 Inactive Maryland License 04/12/2001 Inactive Wisconsin License 02/20/2003 Inactive Ohio License 11/05/2010 10/01/2017

ACADEMIC APPOINTMENTS:

07/2001 – 06/2002 Instructor, Department of Neurology, Johns Hopkins University, School of Medicine, Baltimore, MD

07/2001 – 06/2002 Instructor, Department of Anesthesiology and Critical

Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD

07/2002 – 05//2003 Assistant Professor, Department of Neurology, Johns

Hopkins University, School of Medicine, Baltimore, MD 07/2002 – 05/2003 Assistant Professor, Department of Anesthesiology and

Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD

05/2003 – 06/2006 Assistant Professor, Department of Neurology, Medical

College of Wisconsin, Milwaukee, WI 05/2003 – 06/2006 Assistant Professor, Department of Neurosurgery,

Medical College of Wisconsin, Milwaukee, WI 07/2006 – 12/2010 Associate Professor, Department of Neurology, Medical

College of Wisconsin, Milwaukee, WI 07/2006 – 12/2010 Associate Professor, Department of Neurosurgery,

Medical College of Wisconsin, Milwaukee, WI

12/2010 – 10/2018 Professor, Tenured, Department of Neurology, The

Ohio State University, Columbus, OH

Page 3: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

3

12/2010 – 10/2018 Professor, Tenured, Department of Neurosurgery, The Ohio State University, Columbus, OH

07/2013 – 10/2018 Professor, Tenured, Department of Neurosciences, The

Ohio State University, Columbus, OH

09/2018 – Professor, Tenure Track, Department of Neurology, University of New Mexico, Albuquerque, NM

HOSPITAL STAFF PRIVILEGES:

07/2001 – 05/2003 Staff Attending, Johns Hopkins and Bayview Hospital, Baltimore, MD 07/2003 – 12/2010 Staff Attending, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2004 – 06/2011 Staff Attending, Clement J.Zablocki VA Medical Center, Milwaukee, WI 12/2010 – 10/2018 Staff Attending, The Ohio State University Medical Center, Columbus, OH 09/2018 – Staff Attending, Univ. of New Mexico Health Center, Albuquerque, NM

ADMINISTRATIVE APPOINTMENTS:

07/1998 – 06/1999 Chief Resident in Neurology, University of Massachusetts Medical School, Worcester, MA

07/2002 – 05/2003 Director, Neurovascular Laboratory, Johns Hopkins

University, School of Medicine, Baltimore, MD 07/2003 – 06/2005 Co-Director, Neurocritical Care Unit, Froedtert

Memorial Lutheran Hospital, Milwaukee, WI 07/2003 – 12/2010 Director, Stroke Critical Care Program, Medical

College of Wisconsin, Milwaukee, WI 07/2003 – 12/2010 Director, Stroke Neurocritical Care Fellowship,

Medical College of Wisconsin, Milwaukee, WI 07/2005 – 06/2009 Director, Neurocritical Care Unit, Froedtert Memorial

Lutheran Hospital, Milwaukee, WI 07/2005 – 12/2010 Chief, Neurocritical Care Division, Medical College of

Wisconsin, Milwaukee, WI 07/2006 – 06/2009 Associate Director, Neurosciences Service Line,

Froedtert Memorial Lutheran Hospital, Milwaukee, WI

07/2006 – 12/2010 Associate Neurology Residency Program Director,

Clement J. Zablocki VA Medical Center, Milwaukee, WI

07/2009 – 12/2010 Director, Neurosciences Clinical Research Program,

Medical College of Wisconsin, Milwaukee, WI

Page 4: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

4

12/2010 – 10/2018 Director, Cerebrovascular and Neurocritical Care Division, The Ohio State University, Columbus, OH

12/2010 – 10/2018 Vice Chair for Hospital Affairs, Department of

Neurology, The Ohio State University, Columbus, OH

12/2010 – 10/2018 Medical Director, Neurovascular Stroke Center, The

Ohio State University, Columbus, OH

07/2014 – 10/2018 Medical Director, Neurocritical Care Unit, The Ohio State University Wexner Medical Center, Columbus, OH

07/2015 – 06/2016 Director, Vascular Neurology Fellowship, The Ohio

State University Medical School, Columbus, OH

09/2018 – present Chair, Neurology Department, University of New Mexico, Albuquerque, NM

HOSPITAL – MEDICAL SCHOOL BOARDS AND COMMITTEE SERVICE: Medical College of Wisconsin, Milwaukee, WI

2003 – 2010 Resident Selection Committee, Department of Neurology 2003 – 2006 Resident Selection Committee, Department of Neurosurgery 2004 – 2011 Research Committee, Department of Neurology 2004 – 2009 Education Committee, Department of Neurology 2007 – 2011 Nominating Committee, Faculty Council 2008 – 2011 Research Affairs Committee, Faculty Council

Froedtert Lutheran Memorial Hospital, Milwaukee, WI

2004 – 2011 Critical Care Committee 2006 – 2011 Hospital Advisory Committee 2006 – 2009 Inpatient Services Committee

The Ohio State University Medical School, Columbus, OH

2011 – present Executive Committee, Department of Neurology 2012 – present Governance and Ethics Committee 2013 – 2015 Council on Library and Information Technology 2014 – present Promotion and Tenure Committee

The Ohio State University Wexner Medical Center, Columbus, OH

2011 – present Chair – Stroke Performance Improvement Committee 2011 – present Neurosciences Quality Management Committee 2011 – 2014 Evidence Based Guidelines Committee 2011 – present Quality Committee 2014 – present Neurosciences Executive Committee, Neurosciences Institute

Page 5: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

5

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:

2003 – 2007 President, Board of Directors, American Heart Association

Wisconsin Affiliate 2003 – 2011 Board of Directors, American Heart Association Wisconsin

Affiliate 2004 – 2008 Chair, Wisconsin State Stroke Committee, Department of Human

and Health Services, Madison Wisconsin 2006 – 2008 Advisory Board, Wisconsin Donor Network, Milwaukee,

Wisconsin

NATIONAL/ INTERNATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:

2003 – present Member, Stroke Council, American Heart Association 2003 – present Member, Council on Arteriosclerosis, Thrombosis and Vascular

Biology 2003 – present Member, Interdisciplinary Working Group on Quality of Care and

Outcomes Research, American Heart Association 2005 – 2009 Councilor, Executive Board member, Critical Care and Emergency

Neurology Section, American Academy of Neurology 2006 – 2010 Member-at-large, Section officer, Society of Critical Care Medicine,

Neurosciences Section 2006 – 2009 Member, Acute Advisory Board, National Stroke Association 2007 – 2011 Officer, Board of Directors, Neurocritical Care Society 2009 – 2013 Member, Research Committee, Society of Critical Care Medicine 2009 – 2011 Chair-Elect, Critical Care and Emergency Neurology Section,

American Academy of Neurology 2009 – 2012 Member, Annual Meeting Committee, Neurocritical Care Society 2011 – 2014 Member, Congress Program Committee, Society of Critical Care

Medicine 2011 – 2013 Chair, Critical Care and Emergency Neurology Section, American

Academy of Neurology 2013 – present Past Chair, Critical Care and Emergency Neurology Section,

American Academy of Neurology 2013 – 2014 Secretary, Neurocritical Care Society 2013 – 2014 Chair, Membership Committee, Neurocritical Care Society 2014 – 2015 Treasurer, Neurocritical Care Society 2014 – 2015 Chair, Finance Committee, Neurocritical Care Society 2015 – 2016 Vice President, Neurocritical Care Society 2015 – 2016 Chair, Annual Program Committee, Neurocritical Care Society 2016 – 2017 President, Neurocritical Care Society 2017 – 2018 Immediate Past-President, Neurocritical Care Society 2018 – Past-President, Neurocritical Care Society

AWARDS AND HONORS:

1987- 1989 Dean’s Honor List, American University of Beirut 1996 Certificate of Merit, American College of Physicians

Page 6: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

6

1997 Residency Program Representative, Neurology Resident Symposium, American Neurological Association, San Diego, California

1999 Physician’s Recognition Award, American Medical Association 2000 American Heart Association, Mid-Atlantic Affiliate, Postdoctoral

Fellowship Award 2001 Fellow, American Heart Association, Stroke Council 2004 Leadership Award, Medical College of Wisconsin, Department of

Neurology, Resident award 2008 Fellow, American College of Critical Care Medicine 2008 Torbey Award, Wisconsin Stroke Committee 2008 Resident Teaching Award, Medical College of Wisconsin,

Department of Neurology 2012 - 2015 Presidential Citation, Neurocritical Care Society 2013 Fellow, American Neurological Association 2013 Fellow, Neurocritical Care Society 2018 Fellow, American Academy of Neurology

PROFESSIONAL MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: Member, American College of Physicians (ACP) Member, American Medical Association (AMA) Member, American Academy of Neurology (AAN) Member, Wisconsin Medical Society Member, The Johns Hopkins Medical and Surgical Association Fellow, American Heart Association (AHA), Stroke Council (Fellow) Fellow, Society of Critical Care Medicine Member, American Association for the Advancement of Science Member, American Society of Neuroimaging Vice President, Fellow, Neurocritical Care Society (NCS) Member, Society for Neuroscience Fellow, American Neurological Association (AAN) Member, American College of Physician Executives Member, American College of Health Association EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:

Editorships and Editorial Boards Editor in Chief, Lebanese Medical Students Journal 1993-1994 Editor in Chief, Medical Students International Journal 1993-1995 Member, Editorial Board, Neurological Bulletin 2008-2015 Member, Editorial Board, Current Neurology 2012-present Member, Editorial Board, Austin Journal of Neurosurgery 2015-present Executive Editor, Journal of Neurological Sciences and Psychiatry 2015-present Editor in Chief, Case Studies in Surgery 2015-present Member, Editorial Board, Stroke Research and Therapy 2015-present Ad-hoc Journal Reviewer

Page 7: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

7

Stroke, Critical Care Medicine, Circulation, Metabolism, Journal of Experimental Brain Research, Neurocritical Care, Journal of Cerebral Blood Flow and Metabolism, Archives of Neurology, Cardiology, Journal of Stroke and Cerebrovascular Diseases, Journal of the Neurological Sciences, Neurology, Cerebrovascular Diseases, European Surgical Research

Ad-hoc Peer Grant Review Member, National Peer Review Committee - Brain 1, AHA 2006-2009 Department of Defense, Grant Review Committee 2008 Present Member, National Peer Review Committee - Brain 4, AHA 2011 Member, Special Emphasis Panel Review Group ZAI 1 LGR-M NIH, NIAID 2012 Member, Strategically Focused Disparity Research Network Review Committee, AHA 2014

National Meetings Reviews AAN Therapeutics and Technology Assessment Subcommittee 2001 - present American Academy of Neurology-Cerebrovascular Disease Abstracts Meeting 2001-2005 Society of Critical Care Medicine, Abstract Review Committee 2008-2012 American Stroke Association, Abstract Review Committee 2009-2014 GRANT SUPPORT A. Active

Peer Review

Title: Biomedical Research Facility (PI: Larson) Source: NIH/OD Role: Brain Injury Co-Lead Dates: 2019-2024

Non-Peer Review Title: Efficacy and Safety of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-3) Source: H. Lundbeck A/S Role: Site Co-Investigator Dates: 2011 - 2013 Direct Funds: NA

Title: Glyburide Advantage in Malignant Edema and Stroke – Remedy

Pharmaceuticals (GAMES-RP) Source: Remedy Pharamceuticals Role: Site PI Dates: 2013 - 2016 Direct Funds: NA

Page 8: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

8

Title: A phase 3, randomized, placebo-controlled, double blind study of the combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator (tPA) for emergent revascularization (CLOTBUST-ER) in acute ischemic stroke

Source: Cerevast Therapeutics, Inc. Role: Site PI Dates: 2014 - 2015 Direct Funds: NA

B. Prior

Peer Review

Title: OSU - Neurological Emergencies Treatment Trials Network Clinical Site Source: National Institute of Neurological Disorders (NINDS) Role: Principal Investigator Dates: 2012 - 2018 Direct Funds: $ 1,250,000 (Total for all years) Title: The Ohio State University Regional Coordinating Stroke Center Source: National Institute of Neurological Disorders (NINDS) Role: Principal Investigator Dates: 2013 – 2018 Direct Funds: $1,900,000 (Total for all years)

Title: A Biophysical Plasma Volume Expander that Treats Traumatic Brain Injury. Source: Department of Defense - CDMRP Role: Principal Investigator Dates: 2011 - 2018 Direct Funds: $ 952,590

Title: Safety and Tolerability of Deferoxamine in Acute Intracerebral Hemorrhage Source: National Institute of Neurological Disorders (NINDS) Role: Site PI Dates: 2008 - 2018 Direct Funds: $ 1,000,000 per year Title: Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage

Phase III (CLEAR III) Source: National Institute of Neurological Disorders (NINDS) Role: Site-PI Dates: 2009 – 2019 Direct Funds: $60,000 per year

Title: Antihypertensive Treatment of Cerebral Hemorrhage (ATACH-II) Source: National Institute of Neurological Disorders (NINDS) Role: Site-PI Dates: 2012 - 2019 Direct Funds: NA

Title: Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Source: National Institute of Neurological Disorders (NINDS) Role: Site-PI

Page 9: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

9

Dates: 2012 - 2019 Direct Funds: NA

Title: Progesterone for Acute Traumatic Brain Injury Clinical Trial (PROTECT) Source: National Institute of Neurological Disorders (NINDS) Role: Site-PI Dates: 2007 - 2019 Direct Funds: NA Title: Insights on selected procoagulation markers and outcomes in stroke trial (I-

SPOT) Source: National Institute of Neurological Disorders (NINDS) Role: Site-PI Dates: 2013 - 2019 Direct Funds: NA Title: MISTIE III: A PHASE III, randomized, open-label, 500-subject clinical trial of

minimally invasive surgery plus rt-pa in the treatment of intracerebral hemorrhage

Source: National Institute of Neurological Disorders (NINDS) Role: Site-PI Dates: 2013 - 2019 Direct Funds: NA Title: A multi-center phase 2 study using a CRM to determine the safety and

tolerability of 3K3A-APC, a recombinant variation of human activated protein C (APC), in combination with tPA in moderately severe acute ischemic stroke

Source: National Institute of Neurological Disorders (NINDS) Role: Site Principal Investigator Dates: 2014 - 2019 Direct Funds: NA Title: Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Source: Emory University/ NIH Role: Site Co-Investigator Dates: 1999 –2003 Direct Funds: $ 106,479 Title: Markers and Outcome Predictors of Brain Injury in Patients following Cardiac

Arrest Source: Anesthesiology/ Critical Care Medicine, Johns Hopkins University SOM Role: Principal Investigator Dates: 2000 –2002 Direct Funds: $5,000 Title: Markers and Outcome Predictors of Brain Injury in Patients following Cardiac

Arrest Source: American Heart Association, Mid-Atlantic Affiliate Role: Principal Investigator Dates: 2000 –2001 Direct Funds: $ 30,000

Page 10: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

10

Title: Intraoperative Hypothermia for Aneurysm Surgery Trial Part 2 (IHAST2) Source: University of Iowa/NIH Role: Co-Investigator Dates: 2000 –2003 Direct Funds: NA

Title: Markers and Outcome Predictors of Brain Injury in Patients following Cardiac

Arrest Source: General Clinical Research Grant (GCRC) Role: Principal Investigator Dates: 2001 – 2003 Direct Funds: $19,337

Title: Neurological Consequences of Cardiac Arrest Source: National Institute of Health Role: Co-Investigator Dates: 2001 - 2004 Direct Funds: $ 1,313,313 (for total of 2 years)

Title: Mechanism of Regulation of Cerebral Blood Flow- Cardiac Arrest/CPR:

Mechanisms of Brain Injury in the Newborn Source: National Institute of Neurological Disorders (NINDS) Role: Co-Investigator, Project 4 Dates: 2002 - 2007 Direct Funds: $ 9,359,226

Title: Effect of Recombinant Tissue Plasminogen Activator (rt-PA) on Resolution of

Intraventricular Hemorrhage Source: Food and Drug Administration – Office of Orphan Drug Development Role: Co- Investigator Dates: 2000- 2004 Direct Funds: NA

Title: Mechanisms of Neonatal striatal injury post-asphyxia: Role of Na-K-ATPase” Source: Medical College of Wisconsin - Research Affairs Committee Role: Principal Investigator Dates: 2005 - 2006 Direct Funds: $12,500 (total for all years)

Title: A Biophysical Approach to Resuscitation Fluid Source: National Institute of Neurological Disorders (NINDS) Role: Co-Investigator - Principal investigator: Subcontract Dates: 2004- 2007 Direct Funds: $52,471 (total for all years) Title: A Macromolecular Treatment for Ischemic Stroke Source: National Institute of Neurological Disorders (NINDS) Role: Co-Investigator - Principal Investigator: Subcontract Dates: 2004-2006 Direct Funds: $119,508 (total for all years)

Page 11: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

11

Title: A Biophysical Therapeutic for Traumatic Brain Injury and Other Battelfied Injuries

Source: The Defense Advanced Research Projects Agency (DARPA) Role: Co-Investigator - Principal Investigator: Subcontract Dates: 2008 -2008 Direct Funds: $34,000 Title: Hyperbaric Oxygen Therapy of Stroke (HOTS) Source: Medical College of Wisconsin Role: Co-Investigator Dates: 2008 –2009 Direct Funds: $44,000 Title: Interventional Management of Stroke Trial III (IMS III) Source: National Institute of Neurological Disorders (NINDS) Role: Site co- Principal Investigator Dates: 2005 –2011 Direct Funds: $32,198 (for 1st year of study)

Title: Insulin Resistance Intervention after Stroke (IRIS) Source: National Institute of Neurological Disorders (NINDS) Role: Site Principal Investigator Dates: 2004 –2011 Direct Funds: $193,225 (total for all years) Title: Siblings with Ischemic Stroke Study (SWISS) Source: National Institute of Neurological Disorders (NINDS) Role: Site Principal Investigator Dates: 2006 – 2011 Direct Funds: $274,944 (Total for all years)

Title: MCW- Neurological Emergencies Treatment Trials Network Clinical Site Source: National Institute of Neurological Disorders (NINDS) Role: Co-Principal Investigator Dates: 2007 – 2011 Direct Funds: $ 1,000,000 (Total for all years)

Title: fMRI and Robot-Assisted Practices of Activities of Daily Living. Source: National Institute of Neurological Disorders (NINDS) Role: Mentor Dates: 2008 –2013 Direct Funds: $500,000 per year

Title: Albumin in Acute Stroke Trial- Part 2: A Phase III Randomized Multicenter

Clinical Trial of High Dose Albumin Therapy (ALIAS). Source: National Institute of Neurological Disorders (NINDS) Role: Site- PI Dates: 2009 –2013 Direct Funds: $50,000 per year

Title: Stenting and Aggressive Medical Management for Preventing Recurrent Stroke

in Intracranial Stenosis (SAMMPRIS). Source: National Institute of Neurological Disorders (NINDS)

Page 12: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

12

Role: Neurology Site -PI Dates: 2009 –2011 Direct Funds: $200,000 per year

Title: Role of Near-Infra Red in Traumatic Brain Injury in a cortical Contusion Model Source: Department of Defense Role: Co- PI Dates: 2009 –2010 Direct Funds: $ 125,000

Non-Peer Review Title: REPINOTAN Source: Bayer Role: Site Co-Principal Investigator Dates: 2001 –2003 Direct Funds: NA Title: ARTIST MRI Source: CATO – Yamanucci Role: Co-Investigator Dates: 2001 –2003 Direct Funds: NA

Title: COOLGARDTM Source: Alsius Co. Role: Co-Investigator Dates: 2000 –2003 Direct Funds: NA Title: A Study of Platelet Function in Patients with Intracerebral Hemorrhage Source: The Johns Hopkins University School of Medicine Role: Co-Investigator Dates: 2000 –2003 Direct Funds: NA Title: Early Versus Late Tracheostomy in Intracerebral Hemorrhage and Stroke

Patients Source: The Johns Hopkins University School of Medicine Role: Co-Principal Investigator Dates: 2001 –2003 Direct Funds: NA

Title: SAINT II: intravenous NXY-059 in acute ischemic stroke Source: Astra Zeneca, Inc. Role: Site Principal Investigator Dates: 10/01/2003 – 10/01/2006 Direct Funds: $75,000 (total for all years)

Title: SUN N4057 (Piclozotan) Source: Daiichi Asubio Pharmaceuticals, Inc. Role: Site Principal Investigator Dates: 2006 –2007

Page 13: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

13

Direct Funds: $813,000 (total for all years) Title: PRoFESS Source: Boehringer Ingelheim, Inc. Role: Site Principal Investigator Dates: 2004- 2008 Direct Funds: $91,200 (total for all years) Title: Study of Acute Viprinex™ for Emergency Stroke (ANCROD) Source: Neurobiological Technologies, Inc. Role: Site Principal Investigator Dates: 2006 –2009 Direct Funds: $ 462,720 (total for all years) Title: Benechill Temperature Reduction via Intranasal Cooling in the Neurointensive

Care Source: Benechill, Inc. Role: Site Principal Investigator Dates: 2008 –2009 Direct Funds: $ 100,000

Title: SENTIS Stroke Trial Protocol - Safety and Efficacy of NeuroFlo Technology in

Ischemic Stroke Source: CoAxia, Inc. Role: Site Principal Investigator Dates: 2006 –2011 Direct Funds: NA Title: Evaluation of the Penumbra™ Stroke System in the Revascularization of Patients

with Acute Ischemic Stroke Secondary to Intracranial Large Vessel Occlusive Disease

Source: Penumbra, Inc. Role: Site Co-Investigator Dates: 2006 – 2011 Direct Funds: NA

STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOW MENTORED

TRAINEES

PRESENT POSITION

Till-Karsten Hauser, M.D.

Research Fellow 2000

Neurology Resident Germany

Manuel Buitrago , MD

Post-doctoral Fellow 2000-2001

Neurology Resident Cleveland Clinic Foundation Cleveland, OH

Jonathan Pindrick

Undergraduate pre-Med

Neurosurgery Resident Johns Hopkins Univeristy Baltimore, MD

Page 14: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

14

Clinical Research Student 2001

Diana Green-Chandos, MD, Ph.D

Neurocritical Care Fellow 2001-2002

Neurologist Greater Baltimore Medical Center Baltimore, MD

Chere Chase, MD Neurocritical Care Fellow 2001-2003

Director , Stroke and Neurocritical Care Forseyth Medical Institutions Winston Salem, NC

Robert Stevens, MD Neurocritical Care Fellow 2001 - 2003

Assistant Professor, Attending Anesthesiologist Johns Hopkins University, Baltimore, MD

Anise Ardelt, MD, Ph.D Neurocritical Care Junior Fellow 2002-2003

Assistant Professor, Attending Neurologist University of Alabama

Conny Chen, MD Neurocritical Care Junior Fellow 2002-2003

Attending Neurologist Presbyterian Hospital, Dallas, TX

Wendy Wright, MD Neurocritical Care Junior Fellow 2002-2003

Assistant Professor, Attending Neurologist Neurocritical Care Division Emory University

Ann Helms, MD Neurocritical Care Fellow 2004- 2005

Assistant Professor, Attending Neurologist Medical College of Wisconsin Milwaukee, WI

Danielle Roberson Summer Student 2005

University of Michigan Biology Student

Doug Woo, MD Neurology Resident 2003-2004

Assistant Professor, Attending Neurologist Residency, Program Director Medical College of Wisconsin Milwaukee, WI

Jesse Corry, MD Neurology Resident 2003-2004

Neurocritical Care Fellow Washington Univ- St Louis St. Louis, MO

Santiago Ortega Gutierrez, MD Neurology Resident Neurology Resident

Page 15: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

15

2004- present Medical College of Wisconsin Milwaukee, WI

Viktor Szeder, MD, PhD Neurology Resident

2005- 2008 Neurocritical Care Fellow Columbia Presbyterian Hospital New York, NY

Marta Lopez Vicente, MD Research Fellow 2003-2004

Family Medicine Faculty Medical College of Wisconsin

Michelle Mathews Summer Student 2006

University of Tennessee Biology Student

Katyayani Papatla Summer Student 2006

Homestead High School Milwaukee, WI

Khalid Abdul-Raheem Summer Student 2006

Medical Student Medical College of Wisconsin Milwaukee, WI

Seyed Shahmehdi Research Fellow 2006

St. Mathew University

Thomas Wolfe, MD Neurocritical Care Fellow 2007-2009

Neurointerventional Fellow Medical College of Wisconsin Milwaukee, WI

Dhimant Dani, MD Neurocritical Care Fellow 2008-2010

Neurocritical Care Fellow Medical College of Wisconsin Milwaukee, WI

M. Asif Taqi, MD Neurocritical Care Fellow 2009-2011

Neurocritical Care Fellow Medical College of Wisconsin Milwaukee, WI

Michael Abraham, MD Neurocritical Care Fellow 209-2011

Neurocritical Care Fellow Medical College of Wisconsin Milwaukee, WI

Michelle Johnson, PhD Assistant Professor PM&R

PM&R Departement Medical College of Wisconsin Milwaukee, WI

FORMAL TEACHING ACTIVITIES: Medical Student Education Instructor, 4th year medical students clerkship, UMMC, Worcester 1996-1999 Instructor, ”Neurological Examination Techniques”, UMMC, Worcester 1996-1999 Instructor, “Mind, Brain, and Behavior”, Worcester 1996-1999 Lecturer, 4th year medical students’ clerkship, Johns Hopkins University, Baltimore 2000-2003 Director, neurovascular ultrasound training for Neurosciences critical care fellows 2002-2003 Johns Hopkins University, School of Medicine Lecturer, 3rd year medical students’ clerkship, Neurology Department, MCW 2003 - 2011

Page 16: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

16

Lecturer, 3rd year medical students’ clerkship, Neurology Department, OSU 2011- present

Resident and Fellow Education Lecturer, MICU resident, Internal Medicine Department, MCW 2003 - 2011 Lecturer, NICU resident, Department of Neurology, MCW 2004 - 2011 Course Co-Director, Acute Neurology Course, MCW, Milwaukee, WI 2003 - 2011 Lecturer, NCCU resident, Department of Neurology, OSU 2011 - Present

Page 17: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

17

PART II: BIBLIOGRAPHY

REFEREED JOURNAL PUBLICATIONS/ORIGINAL PAPERS: 1. Torbey MT, Selim M, Bigelow C, Knorr J, Recht L., A quantitative analysis of the loss of distinction

between gray and white matter in comatose patients after cardiac arrest. Stroke. 2000; 31: 2163-2167. 2. Chiang VL, Torbey M, Rigamonti D, Williams MA, Ventriculopleural Shunt Obstruction Caused by

Positive Pressure Ventilation. J Neurosurgery, 2001; 95(1): 116-118. 3. Torbey MT, Hauser T-K, Bhardwaj A, Williams M, Ulatowski JA, Mirski MA, Razumovsky A., The

effect of age on cerebral blood flow velocity and incidence of vasospasm following aneurysmal subarachnoid hemorrhage. Stroke. 2001; 32: 2005-2011.

4. Hillis A.E., Ulatowski J.A., Barker P.B., Torbey M., Ziai W., Beauchamp N.J., Wityk R.J., A pilot

Randomized Trial of Induced Blood Pressure Elevation: Effects on Function and Focal Perfusion in Acute and Subacute Stroke. Cerebrovascular Diseases. 2003; 16:236-246.

5. Ziai WC, Torbey MT, Kickler TS, Oh S, Bhardwaj A, Wityk RJ. Platelet count and function in

spontaneous intracerebral hemorrhage. Journal of Stroke and Cerebrovascular Diseases. 2003; 12(4): 201-206

6. Torbey MT, Geocadin R, Razumovsky A, Rigamonti D, Williams M. Utility of CSF pressure monitoring to identify idiopathic intracranial hypertension without papilledema in patients with chronic daily headache. Cephalalgia. 2004 Jun; 24(6): 495-502.

7. Torbey MT, Geocadin R, Bhardwaj A. Brain arrest neurological outcome scale (BrANOS): predicting mortality and severe disability following cardiac arrest. Resuscitation. 2004 Oct; 63(1): 55-63

8. Helms AK, Torbey MT, Hacein-Bey L, Chyba C, Varelas PN. Standardized protocols increase organ and tissue donation rates in the neurocritical care unit. Neurology. 2004 Nov 23; 63(10):1955-7

9. Luft AR, Buitrago MM, Torbey M, Bhardwaj A, Razumovsky A. Biphasic cerebral blood flow velocity profile in patients with aneurysmal subarachnoid hemorrhage. Neurocritical Care. 2004 1(4): 455-460

10. Varelas PN, Rickert KL, Cusick J, Hacein-Bey L, Sinson G, Torbey M, Spanaki M, Gennarelli TA. Intraventricular Hemorrhage after Aneurysmal Subarachnoid Hemorrhage: Pilot Study of Treatment with Intraventricular Tissue Plasminogen Activator. Neurosurgery. 2005 Feb; 56(2):205-213.

11. Todd MM, Hindman BJ, Clarke M for the IHAS Investigators. Mild Intraoperative Hypothermia During Surgery for Intracranial Aneurysm. NEJM. 2005 Jan; 352(2): 135-145

12. Dull C, Torbey MT. Cerebral vasospasm associated with intraventricular hemorrhage. Neurocrit Care. 2005;3(2):150-2.

13. Helms AK, Whelan HT, Torbey MT. Hyperbaric Oxygen Therapy of Cerebral Ischemia. Cerebrovasc Dis. 2005 Oct 17;20(6):417-426

Page 18: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

18

14. Geocadin RG, Buitrago MM, Torbey MT, Chandra-Strobos N, Williams MA, Kaplan PW. Neurologic prognosis and withdrawal of life support after resuscitation from cardiac arrest. Neurology. 2006 Jul 11;67(1):105-8.

15. Higashida RT, Lahue BJ, Torbey MT, Hopkins LN, Leip E, Hanley DF. Treatment of unruptured

intracranial aneurysms: a nationwide assessment of effectiveness. AJNR Am J Neuroradiol. 2007 Jan;28(1):146-51

16. Yang ZJ, Torbey M, Li X, Bernardy J, Golden WC, Martin LJ, Koehler RC. Dopamine receptor

modulation of hypoxic-ischemic neuronal injury in striatum of newborn piglets. J Cereb Blood Flow Metab. 2007 Jan 10; 1339-51.

17. Lemke DM, Hussain SI, Wolfe TJ, Torbey MT, Lynch JR, Carlin A, Fitzsimmons BF, Zaidat OO.

Taka-Tsubo Cardiomyopathy Associated with Seizures. Neurocrit Care. 2008 March 18; 1518-24. 18. Zaidat OO, Klucznik R, Alexander MJ, for the NIH Multi-Center Wingspan Intracranial Stent

Registry Study Group. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology. 2008 Apr 22; 70(17): 1518-24.

19. Zaidat OO, Wolfe T, Hussain SI, Lynch JR, Gupta R, Delap J, Torbey MT, Fitzsimmons BF. Interventional Acute Ischemic Stroke Therapy with Intracranial Self-Expanding Stent. Stroke. 2008 Jun 12. 2392-5.

20. Sacco RL, Diener HC, Yusuf S, et al; PRoFESS Study Group. Aspirin and extended-release

dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008 Sep 18; 359(12):1238-51. 21. Yusuf S, Diener HC, Sacco RL, et al; PRoFESS Study Group. Telmisartan to prevent recurrent stroke

and cardiovascular events. N Engl J Med. 2008 Sep 18;359(12):1225-37. 22. Diener HC, Sacco RL, Yusuf S, et al; Prevention Regimen for Effectively Avoiding Second Strokes

(PRoFESS) study group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008 Oct;7(10):875-84.

23. Pasternak JJ, McGregor DG, Lanier WL; IHAST Investigators. Effect of nitrous oxide use on long-

term neurologic and neuropsychological outcome in patients who received temporary proximal artery occlusion during cerebral aneurysm clipping surgery. Anesthesiology. 2009 Mar;110(3):563-73.

24. Torbey MT. Intracerebral hemorrhage: what's next? Stroke. 2009 Apr;40(4):1539-40. 25. Ziai WC, Torbey MT, Naff NJ, Williams MA, Bullock R, Marmarou A, Tuhrim S, Schmutzhard E,

Pfausler B, Hanley DF. Frequency of sustained intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Cerebrovasc Dis. 2009;27(4):403-10.

26. Kernan WN, Viscoli CM, Demarco D; IRIS Trial Investigators. Boosting enrollment in neurology

trials with Local Identification and Outreach Networks (LIONs). Neurology. 2009 Apr 14;72(15):1345-51.

27. Todd MM, Hindman BJ, Clarke WR, IHAST Investigators. Perioperative fever and outcome in

surgical patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2009 May;64(5):897-908

Page 19: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

19

28. Wolfe TJ, Torbey MT. Management of Intracranial Pressure. Curr Neurol Neurosci Rep. 2009 Nov; 9(6): 477-85

29. Yang ZJ, Carter EL, Torbey MT, Martin LJ, Koehler RC. Sigma receptor ligand 4-phenyl-1-(4-

phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons. Exp Neurol. 2010 Jan;221(1):166-74

30. Hindman BJ, Bayman EO, Pfisterer WK, Torner JC, Todd MM; IHAST Investigators. No association

between intraoperative hypothermia or supplemental protective drug and neurologic outcomes in patients undergoing temporary clipping during cerebral aneurysm surgery: findings from the Intraoperative Hypothermia for Aneurysm Surgery Trial. Anesthesiology. 2010 Jan; 112(1):86-101

31. Szeder V, Ortega-Gutierrez S, Ziai W, Torbey MT. The TRACH score: clinical and radiological

predictors of tracheostomy in supratentorial spontaneous intracranial hemorrhage. Neurocritical Care. 2010 Apr 15

32. Lopez-Vicente M, Ortega-Gutierrez S, Amlie-Lefond C, Torbey MT. Diagnosis and management of pediatric arterial stroke. J Stroke Cerebrovasc Dis. 2010 May, 19(3):175-83

33. Nguyen HP, Zaroff JG, Bayman EO, Gelb AW, IHAST-MIDS and IHAST Investigators. Perioperative hypothermia does not increase the occurrence of cardiovascular events in patients undergoing cerebral aneurysm surgery: findings from the Intraoperative Hypothermia for Aneurysm Surgery Trial. Anesthesiology. 2010 Aug; 113(2): 327-42

34. Morrison LJ, Deakin CD, Morley PT, Callaway CW, Kerber RE, Kronick SL, Lavonas EJ, Link MS, Neumar RW, Otto CW, Parr M, Shuster M, Sunde K, Peberdy MA, Tang W, Hoek TL, Böttiger BW, Drajer S, Lim SH, Nolan JP; Advanced Life Support Chapter Collaborators. Part 8: Advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2010 Oct 19; 122(16 Suppl 2):S345-421.

35. Shuaib A, Bornstein NM, Diener HC, Dillon W, Fisher M, Hammer MD, Molina CA, Rutledge JN,

Saver JL, Schellinger PD, Shownkeen H; SENTIS Trial Investigators. Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial. Stroke. 2011 Jun; 42(6):1680-90.

36. Chimowitz MI, Lynn MJ, Turan TN, Fiorella D, Lane BF, Janis S, Derdeyn CP; SAMMPRIS

Investigators. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis. 2011 Jul-Aug; 20(4):357-68.

37. Abou-Chebl A, Sung G, Barbut D, Torbey M. Local brain temperature reduction through intranasal

cooling with the RhinoChill device: preliminary safety data in brain-injured patients. Stroke. 2011 Aug;42(8):2164-9.

38. Bushnell CD, Olson DM, Zhao X, Pan W; AVAIL Investigators. Secondary preventive medication

persistence and adherence 1 year after stroke. Neurology. 2011 Sep 20;77(12):1182-90. 39. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL,

Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011 Sep 15;365(11):993-1003.

Page 20: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

20

40. Meschia JF, Nalls M, Matarin M, Brott TG, Brown RD Jr, Hardy J, Kissela B, Rich SS, Singleton A,

Hernandez D, Ferrucci L, Pearce K, Keller M, Worrall BB; Siblings With Ischemic Stroke Study Investigators. Siblings with ischemic stroke study: results of a genome-wide scan for stroke loci. Stroke. 2011 Oct; 42(10):2726-32.

41. Selim M, Yeatts S, Goldstein JN, Gomes J, Greenberg S, Morgenstern LB, Schlaug G, Torbey M, Waldman B, Xi G, Palesch Y; Deferoxamine Mesylate in Intracerebral Hemorrhage Investigators. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke. 2011 Nov;42(11):3067-74.

42. Wijman CA, Smirnakis SM, Vespa P, Szigeti K, Ziai WC, Ning MM, Rosand J; First Neurocritical

Care Research Conference Investigators. Research and technology in neurocritical care. Neurocrit Care. 2012 Feb;16(1):42-54.

43. Hall CE, Mirski M, Palesch YY, Diringer MN, Qureshi AI, Robertson CS, Geocadin R, Wijman CA,

Le Roux PD, Suarez JI; First Neurocritical Care Research Conference Investigators. Clinical trial design in the neurocritical care unit. Neurocrit Care. 2012 Feb;16(1):6-19.

44. Behrouz R, Malek AR, Torbey MT. Small vessel cerebrovascular disease: the past, present, and

future. Stroke Res Treat. 2012; 2012:839151. 45. Silbergleit R, Biros MH, Harney D, Dickert N, Baren J; NETT Investigators. Implementation of the

exception from informed consent regulations in a large multicenter emergency clinical trials network: the RAMPART experience. Acad Emerg Med. 2012 Apr;19(4):448-54.

46. Quirk BJ, Torbey M, Buchmann E, Verma S, Whelan HT. Near-infrared photobiomodulation in an animal model of traumatic brain injury: improvements at the behavioral and biochemical levels. Photomed Laser Surg. 2012 Sep;30(9):523-9.

47. Fiorella D, Derdeyn CP, Lynn MJ, Barnwell SL, Hoh BL, Levy EI, Harrigan MR, Klucznik RP, McDougall CG, Pride GL Jr, Zaidat OO, Lutsep HL, Waters MF, Hourihane JM, Alexandrov AV, Chiu D, Clark JM, Johnson MD, Torbey MT, Rumboldt Z, Cloft HJ, Turan TN, Lane BF, Janis LS, Chimowitz MI; SAMMPRIS Trial Investigators. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke. 2012 Oct;43(10):2682-8.

48. Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, Goldstein FC, Caveney AF, Howlett-Smith H, Bengelink EM, Manley GT, Merck LH, Janis LS, Barsan WG; NETT Investigators. Very early administration of progesterone for acute traumatic brain injury. N Engl J Med. 2014 Dec 25;371(26):2457-66

49. Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A,

Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; SAMMPRIS Trial Investigators. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): The final results of a randomized trial. Lancet. 2014 Jan 25; 383(9914): 333-41

50. Welch RD, Nicholas K, Durkalski-Mauldin VL, Lowenstein DH, Conwit R, Mahajan PV,

Lewandowski C, Silbergleit R; Neurological Emergencies Treatment Trials (NETT) Network Investigators. Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population. Epilepsia. 2015 Feb;56(2):254-62.

Page 21: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

21

51. Torbey MT, Bösel J, Rhoney DH, Rincon F, Staykov D, Amar AP, Varelas PN, Jüttler E, Olson D,

Huttner HB, Zweckberger K, Sheth KN, Dohmen C, Brambrink AM, Mayer SA, Zaidat OO, Hacke W, Schwab S. Evidence-based guidelines for the management of large hemispheric infarction : a statement for health care professionals from the neurocritical care society and the german society for neuro-intensive care and emergency medicine. Neurocrit Care. 2015 Feb;22(1):146-64.

52. Zha AM, Sari M, Torbey MT. Recommendations for management of large hemispheric infarction.

Curr Opin Crit Care. 2015 Apr;21(2):91-8. 53. Zhu Y, Lui F, Zou X, Torbey M. Comparison of unbiased estimation of neuronal number in the rat

hippocampus with different staining methods. J Neurosci Methods. 2015 Oct 30; 254: 73-9

54. Bösel J, Schönenberger S, Dohmen C, Jüttler E, Staykov D, Zweckberger K, Hacke W, Schwab S, Torbey MT, Huttner HB. Intensive care therapy of space-occupying large hemispheric infarction. Summary of the NCS/DGNI guidelines. Nervenarzt. 2015 Aug; 86(8): 1018-29

55. Torbey MT. Brain injury and the lung. J Neuroanaesthesiol Crit Care. 2016; 3, Suppl S1: 20-1

56. Kwon HM, Lynn MJ, Turan TN, Derdeyn CP, Fiorella D, Lane BF, Montgomery J, Janis LS, Rumboldt Z, Chimowitz MI; SAMMPRIS Investigators. Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial. JAMA Neurol. 2016 Jan; 73(1): 36-42.

57. Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M; IRIS Trial Investigators. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack. N Engl J Med. 2016 Apr 7; 374(14):1321-31.

58. Johnston SC, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Jonasson J, Minematsu K, Molina CA, Wang Y, Wong KS; SOCRATES Steering Committee and Investigators. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. N Engl J Med. 2016 Jul 7;375(1):35-43.

59. Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, Moy CS, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Wang Y, Yamamoto H, Yoon BW; ATACH-2 Trial Investigators and the Neurological Emergency Treatment Trials Network. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. N Engl J Med. 2016 Sep 15; 375(11):1033-43

60. Manno EM, Freeman WD, Livesay S, Geocadin RG, Torbey M, Nyquist P, Hemphill C; Expertise Matters. Crit Care Med. 2016 Nov;44(11):e1147-e1148

70. Singh D, Torbey MT, Schwab JM. Modifiable denominators of evolving post-stroke autoimmunity.

J Neuroimmunol. 2016 Nov 15;300:57-58. 71. Hinduja A, Limaye K, Ravilla R, Sasapu A, Papanikolaou X, Wei L, Torbey M, Waheed S. Spectrum

of Cerebrovascular Disease in Patients with Multiple Myeloma Undergoing Chemotherapy- Results of a Case Control Study. PLoS One. 2016 Nov 30;11(11):e0166627.

71. Gulati D, Dua D, Torbey MT. Hemostasis in Intracranial Hemorrhage. Front Neurol. 2017 Mar

15;8:80

Page 22: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

22

72. Geocadin RG, Wijdicks E, Armstrong MJ, Damian M, Mayer SA, Ornato JP, Rabinstein A, Suarez

JI, Torbey MT, Dubinsky RM, Lazarou J. Practice guideline summary: Reducing brain injury following cardiopulmonary resuscitation: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2017 May 30;88(22):2141-2149

73. Torbey MT, Brophy GM, Varelas PN, Bösel J, Manno E, Bader MK, Suarez JI, Seder D, Freeman

WD. Guidelines for Family-Centered Care in Neuro-ICU Populations: Caveats for Routine Palliative Care. Crit Care Med. 2017 Jun;45(6):e620-e621

74. Kowalski RG, Haarbauer-Krupa JK, Bell JM, Corrigan JD, Hammond FM, Torbey MT, Hofmann

MC, Dams-O'Connor K, Miller AC, Whiteneck GG. Acute Ischemic Stroke After Moderate to Severe Traumatic Brain Injury: Incidence and Impact on Outcome. Stroke. 2017 Jul;48(7):1802-1809.

75. Yehya M, Torbey MT. The Role of Mast Cells in Intracerebral Hemorrhage. Neurocrit Care. 2017

Jun 15. doi: 10.1007/s12028-017-0416-5.

76. Easton JD, Aunes M, Albers GW, etal; SOCRATES Steering Committee and Investigators. Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes). Circulation. 2017 Sep 5;136(10):907-916.

76. Sabbouh T, Torbey MT. Malnutrition in Stroke Patients: Risk Factors, Assessment, and Management. Neurocrit Care. 2017 Aug 10. doi: 10.1007/s12028-017-0436-1

77. Fam MD, Zeineddine HA, Eliyas JK, etal; CLEAR III Trial Investigators. CSF inflammatory response after intraventricular hemorrhage. Neurology. 2017 Oct 10;89(15):1553-1560

78. Epstein KA, Viscoli CM, Spence JD, Young LH, etal ; IRIS Trial Investigators. Smoking cessation and outcome after ischemic stroke or TIA. Neurology. 2017 Oct 17;89(16):1723-1729

79. Saver JL, Carroll JD, Thaler DE, Smalling RW, etal; RESPECT Investigators. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. N Engl J Med. 2017 Sep 14;377(11):1022-1032

80. Hussein O, Torbey M. Hyperpyrexia as the Presenting Symptom of Intracranial Hypotension. Neurocrit Care. 2017 Nov 17. doi: 10.1007/s12028-017-0481-9.

81. Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG; DEFUSE 3 Investigators. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018 Jan 24. doi: 10.1056/NEJMoa1713973.

82. Selim M, Hanley D, Broderik J, Hemorrhagic Stroke Academia Industry (HEADS) Roundtable Participants (HEADS), Basic and Translational Research in Intracerebral Hemorrhage: Limitations, Priorities, Recommendations. Stroke. 2018 May; 49(5): 1308-1314

Page 23: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

23

83. Selim M, Hanley D, Broderik J, Hemorrhagic Stroke Academia Industry (HEADS) Roundtable Participants (HEADS), Unmet Needs and Challenges in Clinical Research of Intracerebral hemorrhage. Stroke. 2018 May; 49(5): 1299-1307

84. Johnston SC, Easton JD, Farrant M, Barsan W, NETT Investigators, Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018. Jul 19; 379(3):215-225

85. Hussein O, Sawalha K, Hamed M, Abd ElAzim A, Wei L, Torbey MT, Hinduja A, The Intraventricular Spot-sign: Prevalence, Significance, and relation to hematoma expansion and Outcomes. J Neurol. 2018 Oct; 265(10) 2201-2210

86. Moheet AM, Livesay SL, Abdelhak T, Bleck TP, Human T, Karanjia N, Lamer-Rosen A, Medow J, Nyquist PA, Rosengart A, Smith W, Torbey MT, Chang CWJ. Standards for Neurologic Critical Care Units: A Statement for Healthcare Professionals from The Neurocritical Care Society. Neurocrit Care. 2018 Oct;29(2):145-160

87. Lyden P, Pryor KE, Coffey CS, Cudkowicz M, Conwit R, Jadhav A, Sawyer RN Jr, Claassen J,

Adeoye O, Song S, Hannon P, Rost NS, Hinduja A, Torbey M, Lee JM; NeuroNEXT Clinical Trials Network NN104 Investigators. Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke. Ann Neurol. 2019 Jan;85(1):125-136

88. Greene-Chandos D, Torbey M. Critical Care of Neuromuscular Disorders. Continuum (Minneap

Minn). 2018 Dec;24(6):1753-1775

89. Selim M, Foster LD, Moy CS, Xi G, Hill MD, Morgenstern LB, Greenberg SM, James ML, Singh V, Clark WM, Norton C, Palesch YY, Yeatts SD; i-DEF Investigators. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial.Lancet Neurol. 2019 May;18(5):428-438.

90. Powers CJ, Dornbos D 3rd, Mlynash M, Gulati D, Torbey M, Nimjee SM, Lansberg MG, Albers GW, Marks MP. Thrombectomy with Conscious Sedation Compared with General Anesthesia: A DEFUSE 3 Analysis. AJNR Am J Neuroradiol. 2019 Jun;40(6):1001-1005.

91. Ziai WC, Thompson CB, Mayo S, McBee N, Freeman WD, Dlugash R, Ullman N, Hao Y, Lane K,

Awad I, Hanley DF; Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III) Investigators.Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage: Occurrence and Associations With Outcome. Crit Care Med. 2019 Aug;47(8):1125-1134

92. Suarez JI, Martin RH, Bauza C, Georgiadis A, Venkatasubba Rao CP, Calvillo E, Hemphill JC 3rd,

Sung G, Oddo M, Taccone FS, LeRoux PD; PRINCE Study Investigators. Worldwide Organization of Neurocritical Care: Results from the PRINCE Study Part 1. Neurocrit Care. 2019 Jun 7. doi: 10.1007/s12028-019-00750-3.

93. Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K, Janis S, Durkalski-Mauldin VL; Neurological Emergencies Treatment Trials Network and the SHINE Trial Investigators. Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in

Page 24: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

24

Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. JAMA. 2019 Jul 23;322(4):326-335

94. Silva GS, Maldonado NJ, Mejia-Mantilla JH, Ortega-Gutierrez S, Claassen J, Varelas P, Suarez JI;

Galapagos Neurocritical Care Summit Investigators. Neuroemergencies in South America: How to Fill in the Gaps? Neurocrit Care. 2019 Jul 24. doi: 10.1007/s12028-019-00775-8.

95. Venkatasubba Rao CP, Suarez JI, Martin RH, Bauza C, Georgiadis A, Calvillo E, Hemphill JC 3rd,

Sung G, Oddo M, Taccone FS, LeRoux PD; PRINCE Study Investigators. Global Survey of Outcomes of Neurocritical Care Patients: Analysis of the PRINCE Study Part 2. Neurocrit Care. 2019 Sep 4. doi: 10.1007/s12028-019-00835-z.

BOOKS:

1. Torbey M, Selim MH, 1st ed. The Stroke Book. New York: Cambridge University Press, 2007 2. Torbey M. ed. Neurocritical Care. New York. Cambridge University Press, 2009

3. Torbey M, Selim MH, 2nd ed. The Stroke Book. New York: Cambridge University Press, 2013

4. Miller C.M., Torbey MT., Neurocritical Care Monitoring. New York, Demos Medical Publishing, 2015

BOOK CHAPTERS & REVIEWS:

1. Torbey M, Fisher M. Prophylactic Neuroprotection. In: Fisher M, ed. Prevention of Ischemic stroke. London: Martin Dunitz, 1999

2. Torbey MT, Carhuapoma JR., Intracerebral hemorrhage. Stroke Clinical Updates, National Stroke

Association, 2000. 3. Torbey MT, Bhardwaj A. What is the approach to blood pressure management with Hydralazine in

Patients with Acute Ischemic Stroke?. J Critical Illness, 2000; 15 (11): 590. 4. Torbey MT, Bhardwaj A. Blood pressure management in critically ill neurologic patients. J Critical

Illness, 2001; 16 (4): 179-182 5. Torbey MT, Carhuapoma JR, Critical Care of Guillain-Barre Syndrome. In: Suarez J, ed. Critical

Care Neurology and Neurosurgery. New Jersey: Humana Press, 2004.

6. Torbey MT, Bhardwaj A, Cerebral Blood Flow Physiology and Monitoring. In: Suarez J, ed. Critical Care Neurology and Neurosurgery. New Jersey: Humana Press, 2004.

7. Torbey MT. Thrombolysis: Uses and Abuses in Acute Stroke. Consultant. 2004; 44(4): 597-602 8. Torbey MT, Geocadin R, Less Common Causes of Quadriparesis and Respiratory Failure. In: Suarez

J, ed. Critical Care Neurology and Neurosurgery. New Jersey: Humana Press, 2004.

Page 25: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

25

9. Torbey MT, Neuromuscular Disorders. In: Bhardwaj A, Mirski M, Ulatowski J, ed. Handbook of

Neurocritical Care. New Jersey: Humana Press, 2004.

10. Torbey MT, Blood Pressure Management. In: Bhardwaj A, Mirski M, Ulatowski J, ed. Handbook of Neurocritical Care. New Jersey: Humana Press, 2004.

11. Gordon E, Torbey MT, Extreme Hypertension, Eclampsia, and Critical Care Seizures. In: Varelas P.

ed. Seizures in Critical Care. New Jersey: Humana Press, 2004. 12 Helms AK, Torbey MT, Almassi GH. Determinants of Mortality in Stroke Patients with Right Brain

Damage. Current Atherosclerosis Reports. 2005; July 7(4): 289- 295 13. Geraghty MC, Torbey MT. Neuroimaging and serologic markers of neurologic injury after cardiac

arrest. Neurologic Clinics. 2006; Feb; 24(1): 107-21 14. Chhabria N, Torbey MT. Management of Acute Ischemic Stroke: Reviewing the Options. Applied

Neurology. 2006; May; 2(5): 27- 31 15. Kandiah P, Ortega S, Torbey MT. Biomarkers and neuroimaging of brain injury after cardiac arrest.

Semin Neurol. 2006 Sep;26(4):413-21. 16. Chhabria N, Torbey MT. Acute Ischemic Stroke: Update on New Therapies and the Implications for

Primary Care. Consultant. 2006 Nov; 46(13): 1429-1433 17. Gutierrez SO, Torbey MT. Sentinel headaches in patients with subarachnoid hemorrhage:

implications for patient management. Nat Clin Pract Neurology. 2007 Jun; 3(6):310-1 18. Szeder V, Torbey MT. Prevention and treatment of perioperative stroke. Neurologist. 2008 Jan;

14(1):30-6 19. Lemke D, Torbey MT, Emergency Medical Services: first line of defense against stroke. In: Torbey

M, Selim MH, ed. The Stroke Book. New York: Cambridge University Press, 2007 20. Szeder V, Selim MH, Torbey MT, Perioperative Stroke. In: Torbey M, Selim MH, ed. The Stroke

Book. New York: Cambridge University Press, 2007 21. Lopez Vicente M, Ortega-Gutierrez S, Torbey MT, Stroke on Pediatric Ward. In: Torbey M, Selim

MH, ed. The Stroke Book. New York: Cambridge University Press, 2007 22. Ortega-Gutierrez S, Santa K, Lopez Vicente M, Torbey MT, Vasoactive Therapy. In: Torbey M, ed.

Neurocritical Care. New York: Cambridge University Press, 2009 23. Gordon E, Torbey MT, Extreme Hypertension, Eclampsia, and Critical Care Seizures. In: Varelas P.

ed. Seizures in Critical Care. New Jersey: Humana Press, 2010.

24. Torbey MT, Hydrocephalus. In: Bhardwaj A, Mirski M, ed. Handbook of Neurocritical Care. New Jersey: Humana Press, 2011.

25. Taqi M, Torbey MT, Subarachnoid Hemorrhage. In: Manno E, ed. Emergency Management in

Neurocritical Care. New York: Wiley and Sons, 2012

Page 26: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

26

26. Torbey MT, Miller C. Cerebral Oxygenation. In: Miller C, Torbey M, ed. Neurocritical Care Monitoring. New York: Demos Medical, 2014

EDITORIALS, LETTERS TO EDITOR, OTHER

1. Torbey MT, Bhardwaj A, MR Imaging in comatose Survivors of Cardiac Resuscitation. AJRN. 2002; 23:738

2. Razumovsky A, Bhardwaj A, Hauser T-K, Williams M, Ulatowski JA, Mirski MA, Torbey MT.

Conventional Transcranial Doppler Ultrasonography versus Transcranial Color-Coded Ultrasonography. Stroke. 2002; 33: 641-642.

3. Torbey MT. Decline in Stroke Mortality: Splitters and Lumpers. Stroke. 2003; 34(7): 1615-1616 4. Torbey MT, Geocadin R, Bhardwaj A. Predicting outcome after cardiac arrest: Time for innovation.

Resuscitation. 2005 Jul;66(1):109-10. 5. Torbey MT. The ACE and smoke behind intracerebral hemorrhage. Crit Care Med. 2005;

Aug;33(8):1882-4 6. Helms AK, Whelan HT, Torbey MT. Hyperbaric oxygen therapy of acute ischemic stroke. Stroke

2007 Apr; 38(4):1137 7. Chang CW, Torbey MT, Diringer MN, Coplin W, Mayer SA, Hemphill EC, Chalela JA; Neurocritical

Care Society. Neurointensivists: part of the problem or part of the solution. Crit Care Med. 2008 Oct;36(10):2963-4

8. Torbey MT, Jauch E, Liebeskind DS; Acute Stroke Advisory Board of the National Stroke

Association. Thrombolysis 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Dec 25;359(26):2839

9. Hafeez S, Torbey M. Enhanced external counter pulsation and neurologic recovery for cardiac arrest:

is it ready for prime time?*. Crit Care Med. 2013 Jun;41(6):1593 10. Singh D, Torbey MT, Schwab JM. Modifiable denominators of evolving post-stroke-autoimmunity. J

Neuroimmunol. 2016 May 13. pii: S0165-5728(16)30106-0 MASTER THESIS Torbey M. Predicting Outcome after Cardiac Arrest: Loss of Gray-White matter (LGWM) on CT. 6-1-1999. University of Massachusetts, Amherst.

ABSTRACTS 1. Torbey M. 36 year old male with acute change in mental status. Presented at the American College of

Physician Associates Meeting, Baltimore, MD, May 9, 1996. 2. Torbey M, Recht L. The Case of the wandering uterus. Presented at the Stanley Cobb Resident

Assembly, Boston Society of Neurology and Psychiatry, Boston, MA., 1997.

Page 27: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

27

3. Torbey M, Moonis M. rt-PA experience beyond the NINDS trial. Presented at the 123rd Annual Meeting of the American Neurological Association, Montreal, Canada, October 17, 1998. ANNALS OF NEUROLOGY 44: (3) P18 SEP

4. Torbey M, Paydarfar D, Bigelow C, Recht L. Loss of Gray-White Matter Differentiation (GWMD)

Predicts Poor Patient Outcome after Cardiac Arrest. Presented at the 51st Annual Meeting of the American Academy of Neurology, Toronto, Canada, April 17-24,1999. NEUROLOGY 52: (6) A61-A61 Suppl. 2

5. Torbey MT, Selim M, Bigelow C, Recht L. A Quantitative Analysis of the Loss of Distinction

between Gray and White Matter in Patients After Cardiac Arrest. Presented at the 23rd Annual Meeting of the American Society of Neuroimaging. San Juan, Puerto Rico, January 26-29, 2000.

6. Torbey M, Hauser T-K, Bhardwaj A, Williams M, Ulatowski JA, Mirski MA, Razumovsky A., The

effect of age on cerebral blood flow velocities in aneurysmal subarachnoid hemorrhage. Presented at the 28th Annual Meeting of the Society of Neurosurgical Anesthesia and Critical Care, San Francisco, CA, October 13, 2000. Journal of Neurosurgical Anesthesiology 2000; 4 (12): 404.

7. Torbey M, Hauser T-K, Bhardwaj A, Williams M, Ulatowski JA, Mirski MA, Razumovsky A., Age

is an important determinant in Cerebral Blood Flow Velocities following aneurysmal subarachnoid hemorrhage. Presented at the 24th Annual Meeting of the American Society of Neuroimaging. Las Vegas, Nevada, January 24-27, 2001. Journal of Neuroimaging 2001; 11 (1): 87.

8. Torbey M, Recht L., Detection of loss of gray white matter differentiation (GWMD) on CT scan:

Interrater reliability of CT interpretation by neurologists. Presented at the 24th Annual Meeting of the American Society of Neuroimaging. Las Vegas, Nevada, January 24-27, 2001. Journal of Neuroimaging 2001; 11 (1): 81.

9. Torbey M, Hauser T-K, Bhardwaj A, Williams M, Ulatowski JA, Mirski MA, Razumovsky A.,

Predictive model for MCA and ICA cerebral blood flow velocities changes following aneurysmal subarachnoid hemorrhage. Presented at the 26th American Heart Association International Stroke Conference, February 14-16, Ft. Lauderdale, Florida. Stroke. 2001; 32 (1): 340.

10. Torbey M, Ziai W, Bhardwaj A, Kickler T, Wityk R., The effect of platelet function abnormalities on

the volume of spontaneous intracerebral hemorrhage. Presented at the 26th American Heart Association International Stroke Conference, February 14-16, Ft. Lauderdale, Florida. Stroke. 2001; 32 (1): 358.

11. Williams M.A., Torbey M. T., Geocadin R.G., Razumovsky A.Y., Calvert P., Rigamonti D., Utility

of intracranial pressure monitoring to diagnose pseudotumor cerebri without papilledema. Presented at the 53rd Annual Meeting of the American Academy of Neurology, May 5-11, Philadelphia, PA. Neurology 56(3): A142-A143 (Suppl 3)

12. Torbey M. T., Ziai W., Lin D., Guerrieri G., Bhardwaj A., Bahti N., Mirski M., Ulatowski J.,

Clinical and radiological predictors of tracheostomy in mechanically ventilated patients with spontaneous intracerebral hemorrhage. Presented at the 53rd Annual Meeting of the American Academy of Neurology, May 5-11, Philadelphia, PA. Neurology 56(3): A428 (Suppl 3)

13. Razumovsky A., Torbey M, Hauser T-K, Bhardwaj A, Williams M, Ulatowski JA, Mirski MA,

Cerebral blood flow velocities in older patients following aneurysmal subarachnoid hemorrhage. Presented at the 53rd Annual Meeting of the American Academy of Neurology, May 5-11, Philadelphia, PA. Neurology 56(3): A427 (Suppl 3)

Page 28: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

28

14. Buitrago M., Luft A.R., Torbey M., Bhardwaj A, Razumovsky A., Biphasic blood flow velocity profile in patients with aneurysmal subarachnoid hemorrhage. Presented at the 53rd Annual Meeting of the American Academy of Neurology, May 5-11, Philadelphia, PA. Neurology 56(3): A432-A433 (Suppl 3)

15. Torbey M.T., Ziai W.C., Sung G.Y, Hanley D.F. , Subarachnoid Hemorrahge in Maryland: Role of

Specialty ICU Care. Presented at the 27th American Heart Association International Stroke Conference, February 7-9, St. Antonio, Texas. 2002. Stroke. 2002; 33 (1): P282.

16. Zia W., Torbey M., Naff N., Williams M.A., Tuhrim S., Marmarou T., Bullock R., Hanley D.F.,

Absence of sustained intracranial pressure elevation in severe intraventricular hemorrhage. Presented at the 27th American Heart Association International Stroke Conference, February 7-9, St. Antonio, Texas. 2002. Stroke. 2002; 33 (1): P101.

17. Torbey M.T., Geocadin R., Bhardwaj A., Brain Arrest Neurologic Outcome Scale (BrANOS):

Predicting Mortality following Cardiac Arrest. Presented at the 31st Critical Care Congress of the Society of Critical Care Medicine, January 26-30, San Diego, CA. 2002. Selected for Reference Citation presentation. Crit Care Med 29(12): 597 Suppl. S Dec 2001

18. Ziai W., Torbey M.T., Pindrick J., Bhardwaj A., Surgical Versus Medical Therapy for Large

Hemispheric Infarctions: A Decision Analysis. Presented at the 31st Critical Care Congress of the Society of Critical Care Medicine, January 26-30, San Diego, CA. 2002. Selected for Reference Citation presentation. Crit Care Med 29(12): 406 Suppl. S Dec 2001

19. Chase C.M., Bhardwaj A., Torbey M.T., Intracerebral Hemorrhage in Maryland: Role of a Specialty

Intensive Care Unit. Accepted for poster presentation at the 54rd Annual Meeting of the American Academy of Neurology, April 13-20, 2002, Denver, CO. Neurology 58 (7): A136 (Suppl 3)

20. Ziai W.C., Pindrick J., Torbey M.T., Razumovsky A.Y., Ulatowski J.A., Hillis A.E., Wityk R.J.,

Prospective Assessment of Cerebral Blood Flow Velocities for Induced Blood Pressure Elevation in Subacute Stroke. Accepted for poster presentation at the 54rd Annual Meeting of the American Academy of Neurology, April 13-20, 2002, Denver, CO. Neurology 58 (7): A388 (Suppl 3)

21. Geocadin R.G., Flores-Gumiran O., Torbey M.T., Bhardwaj A., Mirski M.A., Cerebral Herniation

Syndrome: Clinical Course and Immediate Outcome. Poster presentation, 54rd Annual Meeting of the American Academy of Neurology, April 13-20, 2002, Denver, CO. Neurology 58 (7): A135-136 (Suppl 3)

22. Hillis E.H., Ulatowski J.A., Aldrich E., Barker P., Torbey M., Ziai W., Beauchamp N., Wityk R.J., A

Randomized Trial of Induced Blood Pressure Elevation in Acute to Subacute Stroke. Oral presentation, 54rd Annual Meeting of the American Academy of Neurology, April 13-20, 2002, Denver, CO. Neurology 58 (7): A505 (Suppl 3)

23. Dull C., Razumovsky A.Y., Torbey M.T., Utility of Transcranial Doppler in the Diagnosis of

Vasospasm in Intraventricular Hemorrhage. Poster presentation, 25th Annual Meeting of the American Society of Neuroimaging. Tampa Bay, Florida, March 7-10, 2002. Journal of Neuroimaging 2002; 12 (2): 198.

24. Razumovsky A.Y., Hillis A.E., Aldrich E.M., Torbey M.T., Ziai W.C., Wityk R.J., Contrast TCD for

Cerebral Ischemia of Unknown Etiology. Oral and poster presentation, 25th Annual Meeting of the American Society of Neuroimaging. Tampa Bay, Florida, March 7-10, 2002. Journal of Neuroimaging 2002; 12 (2): 193.

Page 29: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

29

25. Razumovsky A.Y., Hillis A.E., Aldrich E.M., Torbey M.T., Ziai W.C., Wityk R.J., Quantitative Characteristic of Emboli During “Bubble-Test”: Preliminary Results. Oral and poster presentation, 25th Annual Meeting of the American Society of Neuroimaging. Tampa Bay, Florida, March 7-10, 2002. Journal of Neuroimaging 2002; 12 (2): 194.

26. Buitrago M., Luft A., Torbey M.T., Bhardwaj A., Razumovsky A.Y., Biphasic Blood Flow Velocity

Profile in Patients with Aneurysmal Subarachnoid Hemorrhage. Poster presentation, 25th Annual Meeting of the American Society of Neuroimaging. Tampa Bay, Florida, March 7-10, 2002. Journal of Neuroimaging 2002; 12 (2): 195.

27. Ziai W.C., Pindrick J., Razumovsky A.Y., Torbey M.T., Ulatowski J.A., Hillis A.E., Wityk R.J.,

Prospective Assessment of Cerebral Blood Flow Velocities for Induced Blood Pressure Elevation in Acute Stroke. Poster presentation, 25th Annual Meeting of the American Society of Neuroimaging. Tampa Bay, Florida, March 7-10, 2002. Journal of Neuroimaging 2002; 12 (2): 196.

28. Higashida, R. T., Justason, B. J., Clark, M., Tuden, D., Torbey, M. T., Hanley, D. F., Endovascular

Treatment of Unruptured Cerebral Aneurysms May Lead to Improved Outcomes and Lower Hospital Resource Use. Oral Presentation, 40th Annual Meeting of the American Society of Neuroradiology. Vancouver, Canada, May 13-17, 2002.

29. Torbey M.T, Hanley D.F, Justason B., Clark M.A., Tuden D., Highashida R.T., Hospital

Characteristics Associated with Improved Discharge Outcomes for Unruptured Cerebral Aneurysms. Presented at the 4th Scientific Forum on Quality of Care and Outcomes Research in CVD and Stroke, Washington, D.C, October 13-14, 2002. Circulation; 106 (12): e88.

30. Torbey M.T., Geocadin R., Bhardwaj A., Brain Arrest Neurologic Outcome Scale (BrANOS): A

Strong Predictor of Outcome Following Cardiac Arrest. Oral presentation, 54rd Annual Meeting of the American Academy of Neurology, April 13-20, 2002, Denver, CO. Neurology 58(7): A158 (Suppl 3)

31. Torbey M.T., Hanley D.F, Justason B., Clark M.A., Tuden D., Highashida R.T., The Effect of

Clinical Experience on Treatment Outcomes and Hospital Resource Use for Unruptured Cerebral Aneurysms. Oral presentation, 54rd Annual Meeting of the American Academy of Neurology, April 13-20, 2002, Denver, CO. Neurology 58 (7): A325 (Suppl 3)

32. Torbey M.T., Martin L.J., Traystman R.J., Koehler R.C. , Dopamine Receptor Antagonist Protect

Against Striatal Damage in Newborn Piglets caused by Asphyxic Cardiac Arrest. Poster presentation at the 28th American Heart Association International Stroke Conference, February 13-15, Phoenix, Arizona. 2003. Stroke 2003; 34 (1): P230.

33. Sangjin O., Torbey M.T., Ziai W.C., Decompressive surgery for brain edema: Trends and practices

in the State of Maryland. Accepted for poster presentation at the 28th American Heart Association International Stroke Conference, February 13-15, Phoenix, Arizona. 2003 Stroke 2003; 34 (1): P148.

34. Janardhan V., Rajajee V., Torbey M.T., Predictors of Morbidity and Mortality in Patients with Non-

Traumatic Cerebellar Hemorrhages: A Systematic Review. Poster presentation at the Sixth Joint Annual Meeting of the AANS/CNS Section on Cerebrovascular Surgery and the American Society of Interventional and Therapeutic Neuroradiology, February 16-19, Phoenix, Arizona. 2003.

35. Torbey MT, Martin LJ, Traystman RJ, Koehler RC. Neuroprotective effect of dopamine receptor

antagonist against striatal damage caused by asphyxic cardiac arrest in newborn piglets. Poster presentation, 55th Annual Meeting of the American Academy of Neurology, March 29 – April 5, 2003, Honolulu, HI. Neurology 60(5): A63 (Suppl 1).

Page 30: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

30

36. Torbey MT, Pindrick J, Ziai WC. Should patients be included in decision making regarding the choice of thrombolytic therapy in acute stroke?. Poster presentation, 55th Annual Meeting of the American Academy of Neurology, March 29 – April 5, 2003, Honolulu, HI. Neurology 60(5): A225 (Suppl 1).

37. Geocadin RG, Buitrago M, Torbey MT, Williams MA, Hanley DF, Kaplan PK., The impact of

neurological prognostication by clinical examination, EEG and cortical evoked potentials on withdrawal of life sustaining therapies in patients resuscitated from cardiac arrest. Poster presentation, 55th Annual Meeting of the American Academy of Neurology, March 29 – April 5, 2003, Honolulu, HI. Neurology 60(5): A362 (Suppl 1).

38. Ziai WC, Torbey MT, Oh S., Trends and practices of decompressive surgery for refractory brain

edema. Poster presentation, 55th Annual Meeting of the American Academy of Neurology, March 29 – April 5, 2003, Honolulu, HI. Neurology 60(5): A362 (Suppl 1). Selected for the scientific highlights.

39. Torbey M.T., Pindrick J., Ziai W.C., Thrombolysis in acute stroke: What is the best therapeutic

choice? . Oral presentation at the 32nd Critical Care Congress of the Society of Critical Care Medicine, January 28 - February 3, San Antonio, TX. 2003. CRIT CARE MED 31 (2): 23 Suppl. S FEB 2003

40. Torbey M.T., Justason B.J., Leip E, Hopkins L.N., Higashida R., Hanley DF., Do Academic

Training Programs Improve Treatment Outcomes for Unruptured Aneurysm Patients? Oral presentation at the Sixth Joint Annual Meeting of the AANS/CNS Section on Cerebrovascular Surgery and the American Society of Interventional and Therapeutic Neuroradiology, February 16-19, Phoenix, Arizona. 2003.

41. Golden WC, Torbey MT, Li XL, Martin LJ, Koehler RC. Dopamine antagonists prevent loss of

striatal Na, K ATPase activity after hypoxia-ischemia. Poster Presentation at the Pediatrics Academic Societies Annual Meeting, May 3 – 6, 2003 Seattle, WA. PEDIATRIC RESEARCH 53 (4): 134 Part 2 Suppl. S APR 2003.

42. Fedder W, Golembieski A, Conti M, Book D, Torbey MT. Stroke prevention 2003: Are we any

closer to adequate blood pressure control? Poster presentation at the North American Stroke Meeting of the National Stroke Association, December, Orlando, Florida. 2003.

43. Torbey M.T., Ziai W.C., Lin D., Guerrieri G., Varelas P., TRACH scale: a strong predictor of

tracheostomy in mechanically ventilated patients with spontaneous intracerebral hemorrhage. Poster presentation at the 29th American Heart Association International Stroke Conference, February 5-7, San Diego, California. 2004 Stroke 2004; 35 (1): P338.

44. Helms A, Torbey MT, Chyba C, Varelas PN, Neurointensivist driven implementation of brain death

protocols and un-coupling increases organ donation rates. Oral Presentation at the Second Neurocritical Care Meeting of the Neurocritical Care Society, Feb 7-8, San Diego, California. 2004.

45. Varelas PN, Conti M, Torbey MT, Medical record documentation increased after a neurointensivist

appointment in the neuroscience intensive care unit. Poster Presentation at the Second Neurocritical Care Meeting of the Neurocritical Care Society, Feb 7-8, San Diego, California. 2004.

46. Torbey M.T., Martin L.J., Traystman R.J., Koehler R.C., Dopamine Receptor Antagonist Protect

Against Striatal Damage in Newborn Piglets caused by Asphyxic Cardiac Arrest. Poster Presentation at the Second Neurocritical Care Meeting of the Neurocritical Care Society, Feb 7-8, San Diego, California. 2004.

Page 31: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

31

47. Woo D, Peltier W, Hacein-Bey L, Torbey MT, Endovascular management of acute carotid artery

occlusion following administration of intravenous rt-PA. Poster Presentation at the Second Neurocritical Care Meeting of the Neurocritical Care Society, Feb 7-8, San Diego, California. 2004.

48. Helms A, Fedder W, Book D, Binder J, Worman D, Varelas P, Golembiewski A, Torbey MT, Effect

of handiness on intravenous rt-PA administration in acute stroke patients. Poster Presentation at the Second Neurocritical Care Meeting of the Neurocritical Care Society, Feb 7-8, San Diego, California. 2004.

49. Torbey MT, Pindrick J, Ziai W, Thrombolysis in acute stroke: Is combined therapy the best

approach? Oral Presentation at the Second Neurocritical Care Meeting of the Neurocritical Care Society, Feb 7-8, San Diego, California. 2004.

50. Varelas P, Rickert K, Cusick J, Hacein-Bey L, Sinson G, Torbey MT, Gennarelli T, Intraventricular

hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular t-PA. Poster Presentation at the Second Neurocritical Care Meeting of the Neurocritical Care Society, Feb 7-8, San Diego, California. 2004.

51. Helms A, Torbey MT, Chyba C, Varelas PN, Neurointensivist driven implementation of brain death

protocols and un-coupling increases organ donation rates. Oral Presentation at the Second Neurocritical Care Meeting of the Neurocritical Care Society, Feb 7-8, San Diego, California. 2004.

52. Torbey M.T., Ziai W.C., Lin D., Varelas P., TRACH scale accurately predicts need for tracheostomy

in mechanically ventilated patients with spontaneous intracerebral hemorrhage. Poster presentation, 56th Annual Meeting of the American Academy of Neurology, April 24 – May 1, 2004, San Francisco, CA. Neurology 62 (7): A363 (Suppl 5).

53. Helms AK, Torbey MT, Hacein-Bey L, Chyba C, Varelas PN., Implementation of brain death

protocols increases organ donation rates in the neurological intensive care unit. Oral presentation, 56th Annual Meeting of the American Academy of Neurology, April 24 – May 1, 2004, San Francisco, CA. Neurology 62 (7): A447 (Suppl 5). Selected for the meeting scientific highlight presentation.

54. Varelas PN, Eastwood D, Yun HJ, Spanaki MV, Torbey MT, Jaradeh S, Gennarelli T., The impact

of a neurointensivist on a semi-closed neurosciences intensive care unit. Oral presentation, 56th Annual Meeting of the American Academy of Neurology, April 24 – May 1, 2004, San Francisco, CA. Neurology 62 (7): A449 (Suppl 5). Selected for the meeting scientific highlight presentation.

55. Helms AK, Fedder W, Book D, Binder J, Worman D, Golembiewski A, Varelas P, Torbey MT.,

Predictors of IV rt-PA administration within 1 hour of presentation of acute ischemic stroke. Poster presentation, 56th Annual Meeting of the American Academy of Neurology, April 24 – May 1, 2004, San Francisco, CA. Neurology 62 (7): A463 (Suppl 5).

56. Hacein-Bey L., Roman R., Lemke D., Lauer K.K., Varelas P.N., Torbey M.T., Cusick J.F., Harder

D.R., Evaluation of 20-Hydroxyeiscosatetraenoic Acid (20-HETE) levels in normal and abnormal blood and CSF. Accepted for oral presentation at the 42nd Annual meeting of the American Society of Neuroradiology, June 5-11, Seattle, Washington. 2004.

57. Torbey M.T., Ziai W.C., Varelas P., Clinical and radiological predictors of tracheostomy in

mechanically ventilated patients with spontaneous intracerebral hemorrhage. Oral presentation at the Rachidian Society Meeting, February 22-26, Kona, Hawaii. 2004.

Page 32: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

32

58. Torbey M.T, Justason B.J., Leip E, Hopkins L.N., Higashida R., Hanley DF., Do Academic Training Programs Improve Treatment Outcomes for Unruptured Aneurysm Patients? Oral presentation at the Rachidian Society Meeting, February 22-26, Kona, Hawaii. 2004.

59. Torbey M. T., Geocadin R.G., Razumovsky A.Y., Rigamonti D., Williams M.A., Utility of

intracranial pressure monitoring to diagnose pseudotumor cerebri without papilledema. Oral presentation at the Rachidian Society Meeting, February 22-26, Kona, Hawaii. 2004

60. Torbey M.T., Ziai W.C., Varelas P., TRACH scale: a strong predictor of tracheostomy in

mechanically ventilated patients with spontaneous intracerebral hemorrhage. Oral presentation at the Rachidian Society Meeting, February 22-26, Kona, Hawaii. 2004.

61. Helms AK, Whelan HT, Torbey M.T., Hyperbaric oxygen therapy of stroke (HOTS): a randomized

controlled trial. Poster Presentation at the Third Annual Meeting of the Neurocritical Care Society, Feb 25-27, Scottsdale, Arizona. 2005.

62. Varelas P, Eastwood D, Yun H, Spanaki M, Helms A, Torbey M.T., Hacein-Bey L, The impact of a

neurointensivist on short-term stroke outcomes. Poster Presentation at the Third Annual Meeting of the Neurocritical Care Society, Feb 25-27, Scottsdale, Arizona. 2005.

63. Corry J, Gordon E, Helms A, Varelas P, Torbey M.T., Recurrent neuroleptic malignant syndrome

induced by Lithium. Poster Presentation at the Third Annual Meeting of the Neurocritical Care Society, Feb 25-27, Scottsdale, Arizona. 2005.

64. Smith H, Conti M, Helms A, Torbey M.T., Varelas P, Vasopressors and the adult propofol infusion

syndrome: single center experience. Poster Presentation at the Third Annual Meeting of the Neurocritical Care Society, Feb 25-27, Scottsdale, Arizona. 2005.

65. Corry J, Connor M, Helms A, Torbey M.T., Can transcranial Doppler with agitated saline be used as

an initial screening tool for the evaluation of patent foramen ovale in cryptogenic stroke patients. Oral presentation at the 28th Annual Meeting of the American Society of Neuroimaging, March 3 – 6, 2005, Orlando, Florida.

66. Geocadin R.G., Hartman T, Hathi M, Crone N, Torbey M.T., Venkatesha S., Natarajan A., Thakor

N., Hanley D.F. Early Quantitative EEG after Cardiac Arrest Correlates with Functional Outcome: A Pilot Study. Poster presentation, 57th Annual Meeting of the American Academy of Neurology, April 9 – 16, 2004, Miami Beach, Florida. Neurology 64 (6): A307 (Suppl 1).

67. Geocadin R.G., Hartman T, Venkatesha S., Torbey M.T., Crone N, Gharieb R, Schulman S,

Natarajan A., Thakor N., Hanley D.F. Early Quantitative EEG and functional outcome after resuscitation from cardiac arrest. Circulation 112(17): U382-U382. Suppl 2 Oct 25, 2005.

68. Szeder V, Ortega-Gutierrez S, Torbey M.T. TRACH scale: An accurate predictor of successful

ventilator wean and extubation in the neurointensive care unit. Oral presentation, 58th Annual Meeting of the American Academy of Neurology, April 1 – 8, 2006, San Diego, California. Neurology 66 (5): A154 (Suppl 2).

69. Ortega-Gutierrez S, Jones B, Roberson D, Chhabria N, Torbey M.T. Adenosine antagonist prevent

loss of striatal Na, K ATPase activity after hypoxia-ischemia. Poster presentation, 58th Annual Meeting of the American Academy of Neurology, April 1 – 8, 2006, San Diego, California. Neurology 66 (5): A243 (Suppl 2).

Page 33: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

33

70. Szeder V, Ortega-Gutierrez S, Torbey MT, TRACH Scale: a predictor of successful extubation in the neurointensive care unit. Annals of Neurology, 60:S33 Suppl. 10 2006

71. Szeder V, Ortega-Gutierrez S, Torbey MT, TRACH Scale: an accurate predictor of successful

ventilator wean and extubation in the neurointensive care unit. Oral Presentation at the Fourth Annual Meeting of the Neurocritical Care Society, Nov 4-5, Baltimore, Maryland. 2006

72. Ortega-Gutierrez S, Szeder V, Abdul Raheem K, Shahmedi S., Torbey MT, The effect of a closed

neurointensive care unit on outcome in intracerebral hemorrhage. Poster Presentation at the Fourth Annual Meeting of the Neurocritical Care Society, Nov 4-5, Baltimore, Maryland. 2006.

73. Abdul Raheem K, Ortega-Gutierrez S, Shahmedi S., Papatal K, Szeder V, Torbey MT, Intracerebral

Hemorrhage: What is the best therapeutic approach. Poster Presentation at the Fourth Annual Meeting of the Neurocritical Care Society, Nov 4-5, Baltimore, Maryland. 2006.

74. Reddy LV, Zaidat OO, Torbey MT, Intravenous argatroban and microcatheter directed continuous

intrasinus rt-PA for cerebral venous thrombosis. Poster Presentation at the Fourth Annual Meeting of the Neurocritical Care Society, Nov 4-5, Baltimore, Maryland. 2006.

75. Lemke D, Zaidat S., Torbey MT, Role of cathecholamine in neurogenic pulmonary edema in

subarachnoid hemorrhage. Poster Presentation at the Fourth Annual Meeting of the Neurocritical Care Society, Nov 4-5, Baltimore, Maryland. 2006.

76. Reddy LV, Mellor A, Torbey MT, Successful recovery from prolonged pharmacological coma for

refractory status epilepticus. Poster Presentation at the Fourth Annual Meeting of the Neurocritical Care Society, Nov 4-5, Baltimore, Maryland. 2006.

77. Ortega-Gutierrez S, Szeder V, Abdul Raheem K, Shahmedi S., Torbey MT, The effect of a closed

neurointensive care unit on outcome in intracerebral hemorrhage. Poster Presentation at the 36th Critical Care Congress of the Society of Critical Care Medicine, Februrary 17-21, Orlando, Florida. 2007. Crit Care Med 34(12): A144 Suppl. Dec 2006

78. Torbey M.T., Szeder V., Ortega S., Can TRACH scale successfully predict ventilatory wean and

extubation in the neurointensive care unit. Oral presentation at the Rachidian Society Meeting, February 5-9, Kona, Hawaii. 2006

79. Torbey M.T., Ortega S., Jones B., Roberson D., Chhabria N., Adenosine antagonist prevent loss of

striatal Na, K ATPase activity after hypoxia-ischemia. Oral presentation at the Rachidian Society Meeting, February 5-9, Kona, Hawaii. 2006

80. Ortega-Gutierrez S, Szeder V, Shahmehdi S, Abdul-Raheem K, Torbey M.T. The effect of closed

neurointensive care unit on outcome in intracerebral hemorrhage. Poster presentation, 59th Annual Meeting of the American Academy of Neurology, April 28 – May 5, 2007, Boston, MA. Neurology 68 (12): A204 (Suppl 1).

81. Torbey MT, Jones B, Zikria B, Toole J, Macolini K, A Novel Approach to Treatment of Cererbal

Edema Post Cardiac Arrest. Oral Presentation at the Fifth Annual Meeting of the Neurocritical Care Society, Nov 2-3, Las Vegas, Nevada. 2007. Neurocritical Care 2008; 8: 76.

82. Ortega-Gutierrez S, Szeder V, Wolfe T, Lopez-Vicente M, Diaz V, Reddy V, Torbey MT, Predictors

of Outcomes in a Closed versus Semi-closed Neurointensive Care Unit. Oral Presentation at the Fifth Annual Meeting of the Neurocritical Care Society, Nov 2-3, Las Vegas, Nevada. 2007. Neurocritical Care 2008; 8: 83.

Page 34: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

34

83. Szeder V, Ortega-Gutierrez S, Lopez-Vicente M, Wolfe T, Diaz V, Reddy V, Torbey MT, Predictors

of Withdrawal of Care in Intracerebral Hemorrhage Patients. Poster Presentation at the Fifth Annual Meeting of the Neurocritical Care Society, Nov 2-3, Las Vegas, Nevada. 2007. Neurocritical Care 2008; 8: 230.

84. Szeder V, Ortega-Gutierrez S, Lopez-Vicente M, Wolfe T, Diaz V, Reddy V, Torbey MT,

Intracerebral Hemorrhage: Predictors of Withdrawal of Care. Poster presentation, 60th Annual Meeting of the American Academy of Neurology, April 12-19, 2008, Chicago, IL.

85. Ortega-Gutierrez S, Szeder V, Wolfe T, Lopez-Vicente M, Diaz V, Reddy V, Torbey MT,

Intracranial Hemorrhage: Predictors of Outcomes in a Closed versus Semi-closed Neurointensive Care Unit. Poster presentation, 60th Annual Meeting of the American Academy of Neurology, April 12-19, 2008, Chicago, IL.

86. Ortega-Gutierrez S, Jones B, Nawrocky J, Sanchez S, Torbey MT, Dopamine Receptor Modulation

of Cortical and Striatal Na/K ATPase after Cardiac Arrest. Poster Presentation at the Sixth Annual Meeting of the Neurocritical Care Society, Oct 23-25, Miami, Florida. 2008. Neurocritical Care 2008; 9: S102.

87. Pandya D, Wolfe T, Kandiah P, Shah P, Lemke D, Lynch J, Fitzsimmons B-F, Zaidat O, Helms A,

Torbey MT, CT Findings in Hypothermia for Intracerebral Hemorrhage. Poster Presentation at the Sixth Annual Meeting of the Neurocritical Care Society, Oct 23-25, Miami, Florida. 2008. Neurocritical Care 2008; 9: S157.

88. Wolfe T, Shah P, Lemke D, Dani D, Lynch J, Fitzsimmons B-F, Zaidat O, Helms A, Torbey MT,

Impact of Therapeutic Hypothermia on Intracranial Pressure Management. Poster Presentation at the Sixth Annual Meeting of the Neurocritical Care Society, Oct 23-25, Miami, Florida. 2008. Neurocritical Care 2008; 9: S160.

83. Ortega-Gutierrez S, Shah P, Madden J, Garcia JJ, Torbey MT. Pinoline: A Novel Neuroprotective

Therapy in Focal Cerebral Ischemia, 61th Annual Meeting of the American Academy of Neurology, April 25- May 2, 2009, Seattle, WA. Neurology, 72(11): A400-A401 Suppl. 3 March 17, 2009.

84. Ortega-Gutierrez S, Shah P, Buchmann E, Henry MH, Torbey MT, Whelan HT. Neuroprotective

Effect of Near-Infrared Light Emitting Treatment in Stroke, 61th Annual Meeting of the American Academy of Neurology, April 25- May 2, 2009, Seattle, WA. Neurology, 72(11): A402 Suppl. 3 March 17, 2009.

85. Shah P, Ortega-Gutierrez S, Madden J, Garcia JJ, Torbey MT. Melatonin Neuroprotection during

Focal Cerebral Ischemia, 61th Annual Meeting of the American Academy of Neurology, April 25- May 2, 2009, Seattle, WA. Neurology, 72(11): A398 Suppl. 3 March 17, 2009.

86. Dani D, Wolfe T, Lynch J, Zaidat O, Fitzsimmons BF, Torbey MT. Incidence of Adrenal

Insufficiency in Neurointensive Care Unit, 61th Annual Meeting of the American Academy of Neurology, April 25- May 2, 2009, Seattle, WA. Neurology, 72(11): A76 Suppl. 3 March 17, 2009.

87. Wolfe T, Dani D, Lemke D, Shah P, Helms A, Fitzsimmons BF, Lynch J, Zaidat O, Torbey MT.

Differential Radiographic Findings Following Therapeutic Hypothermia For Ischemic and Hemorrhagic Stroke, International Stroke Conference 2009, February 18-20, 2009, San Diego, CA. Stroke, 40(4): E237 Apr 2009.

Page 35: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

35

88. Sung G, Torbey MT, Abou-Chebl A. Rhinochill: A Novel Brain Hypothermia Delivery Device, 61th Annual Meeting of the American Academy of Neurology, April 25- May 2, 2009, Seattle, WA. Neurology, 72(11): A75 Suppl. 3 March 17, 2009.

89. Wolfe T, Miller-Niklasch D, Dani D, Abraham M, Taqi M, Lynch J, Torbey MT, High Rate of

Myopathy in Aneurysmal Subarachnoid Hemorrhage. Poster Presentation at the Seventh Annual Meeting of the Neurocritical Care Society, Nov 11-14, New Orleans, LA. 2009. Neurocritical Care 2009; 11: S70.

90. Abraham M, Wolfe T, Taqi M, Dani D, Miller-Niklasch D, Lynch J, Torbey MT, Serum Creatinine

and Creatinine Clearance Changes Associated with Therapeutic Hypothermia. Poster Presentation at the Seventh Annual Meeting of the Neurocritical Care Society, Nov 11-14, New Orleans, LA. 2009. Neurocritical Care 2009; 11: S72.

91. Taqi M, Wolfe T, Abraham M, Dani D, Lynch J, Torbey MT, Coagulation Abnormalities Associated

with Therapeutic Hypothermia. Poster Presentation at the Seventh Annual Meeting of the Neurocritical Care Society, Nov 11-14, New Orleans, LA. 2009. Neurocritical Care 2009; 11: S150.

92. Ortega Gutierrez S, Shah P, Madden J, Garcia Garcia J, Torbey MT, Neuroprotective Effect of

Melatonin and Pinoline in Focal Cerebral Ischemia. Poster Presentation at the Seventh Annual Meeting of the Neurocritical Care Society, Nov 11-14, New Orleans, LA. 2009. Neurocritical Care 2009; 11: S180.

93. Parikh GC, Wolfe T, Asif K., Miller-Nilasch DM, Jaradeh S, Lynch JR, Torbey MT. High Rate of

Myopathy in Aneurysmal Subarachnoid Hemorrhage Patients, 62 th Annual Meeting of the American Academy of Neurology, April 10 -17, 2010, Toronto, Canada. Neurology, 74(9): A32 Suppl. 2 March 2, 2010.

94. Herrick DB, Hathi M, Schulman S, Pantle H, Chandra-Strobos N, Sinha S, Torbey MT, Peberdy,

MA, Foreman PJ, Hysko T, Natarajan, Kaplan P, Hanley DF, Geocadin RG, Feasibility and Quality of Rapid Standard EEG Testing in Post Cardiac Arrest Patients. Circulation, 122(21):A219. Nov 23, 2010.

95. Geocadin RG, Herrick DB, Hathi M, Schulman S, Pantle H, Chandra-Strobos N, Sinha S, Torbey

MT, Peberdy, MA, Foreman PJ, Hysko T, Natarajan, Hanley DF, Kaplan P, Intermittent EEG Testing and the Diagnosis and Treatment of Seizures after Cardiac Arrest . Circulation, 122(21):A239. Nov 23, 2010

96. Taqi M, Lynch J, Torbey M.T., Magnesium Sliding Scale for Subarachnoid Hemorrhage. Presented

at the 40th Critical Care Congress of the Society of Critical Care Medicine, January 15-19, San Diego, CA. 2011. Crit Care Med 38(12): U261 Suppl. S Dec 2010

97. Taqi M, Lynch J, Torbey M.T., Correlation between Anemia and Delayed Cerebral Ischemia (DCI)

after Aneurysmal Subarachnoid Hemorrhage. Presented at the 40th Critical Care Congress of the Society of Critical Care Medicine, January 15-19, San Diego, CA. 2011. Crit Care Med 38(12): U209 Suppl. S Dec 2010

98. Sweis RT, Badruddin A, Asif K, Taqi M, Torbey MT. Correlation between Delayed Cerebral

Ischemia/Vasospasm and Aneurysm Location after Aneurysmal Subarachnoid Hemorrhage, 63 th Annual Meeting of the American Academy of Neurology, April 09 -16, 2011, Honolulu, HI. Neurology, 76(9): A318 Suppl. 4 March 1, 2011.

Page 36: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

36

99. Abraham MG, Taqi M, Pandya DJ, Gupta P, Torbey MT. Prediction of Hydrocephalus Based on the Location of Intraventricular Hemorrhage after Aneurysmal Subarachnoid Hemorrhage, 63 th Annual Meeting of the American Academy of Neurology, April 09 -16, 2011, Honolulu, HI. Neurology, 76(9): A313 Suppl. 4 March 1, 2011.

100. Whelan H, Torbey MT, Verma S, Quirk B, Jones N, Nawrocki JL, Buchman E. Long-Wavelength

Low Intensity Photon Therapy (LLPT) for Traumatic Brain Injuries, 63 th Annual Meeting of the American Academy of Neurology, April 09 -16, 2011, Honolulu, HI. Neurology, 76(9): A162 Suppl. 4 March 1, 2011.

101. Asi KM, Taqi M, Pandya DJ, Gupta P, Abraham M, Torbey MT. Safety of Administering

Subcutaneous Heparin for Deep Venous Thrombosis Prophylaxis after Aneurysmal Subarachnoid Hemorrhage (aSAH), 63 th Annual Meeting of the American Academy of Neurology, April 09 -16, 2011, Honolulu, HI. Neurology, 76(9): A318 Suppl. 4 March 1, 2011.

102. Taqi. MA, Asi K., Asif, K., Torbey M.T, Correlation between Anemia and Delayed Cerebral

Ischemia (DCI) in aneurysmal subarachnoid hemorrhage. Poster presentation at the 2011 American Heart Association International Stroke Conference, February 8-10, Los Angelos, California. 2011 Stroke 2011; 42 (3): E349.

103. Mutgi S, Greene-Chandos D, Torbey MT, Behrouz R, Tuberculous Meningtis in a Healthy Young

Woman: Case Report and Review of Literature, 64 th Annual Meeting of the American Academy of Neurology, April 21-28, 2012, New Orleans, LA. Neurology, 78: P03250. Suppl. 1 April, 2012.

104. Castellon Larios K., Rybka K., Greene-Chandos D., Bergese S., Torbey M.T., The effect of

telestroke on tissue plasminogen activator utilization and door to needle time on rural hospitals. Accepted for poster presentation at the American Heart Association International Stroke Conference, February 12-14, San Diego, California. Stroke 2014; 46: AWP240.

105. Ortega Gutierrez S., Calleja M., Shah P., Delgado S., Agarwal S., Cunningham A., Sajjad R., Szeder

V., Torbey M.T., Influence of Withdrawal of Care on Spontaneous Intracerebral Hemorrhage Predictive Scales. Accepted for poster presentation at the American Heart Association International Stroke Conference, February 12-14, San Diego, California. Stroke 2014; 46: AWP256.

106. Mutgi S., Lafountain N., Grose N., Torbey M.T., Behrouz Z., Practice diversity among US

Neurologists with respect to the 3 to 4.5-hour window for acute stroke thrombolysis. Accepted for poster presentation at the American Heart Association International Stroke Conference, February 11-13, Nashville, Tennessee. Stroke 2015; 46: AWP55.

107. Lui F, Zhu Y, Zou X, Torbey MT, Quantitative hippocampal neuron changes following BPZ

treatment in traumatic brain injury. Poster Presentation at the Thirteenth Annual Meeting of the Neurocritical Care Society, October 7-10, Scottsdale, AZ. 2015. Neurocritical Care 2015; 23: S47.

108. Zhu Y, Lui F, Zou X, Torbey MT, The role of mast cells, AQP-4 and MMP-9 in brain edema after

traumatic brain injury. Poster Presentation at the Thirteenth Annual Meeting of the Neurocritical Care Society, October 7-10, Scottsdale, AZ. 2015. Neurocritical Care 2015; 23: S58.

Page 37: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

37

PART III: LECTURES INVITED LECTURES/WORKSHOPS/PRESENTATIONS:

INVITED LECTURES

Grand Rounds, University of Massachusetts Medical School, Department of Neurology, Worcester “Unusual case of Headache: Just the tip of the iceberg”, November 24, 1998. Grand Rounds, University of Massachusetts Medical School, Department of Neurology, Worcester “Intra-arterial vs. Intravenous Thrombolytics: Review of the Literature”, October 28, 1997. 26th Neurology Department Research Dinner, University of Massachusetts Medical School, Department of Neurology, Worcester “Predicting Outcome in Cardiac Arrest using CT scan”, April 19, 1999 Grand Rounds, Medical University of South Carolina, Department of Neurology, Charleston, “Neurological Recovery After Cardiac Arrest: The Hounsfield Unit Factor”, December 21, 2000. Treatment of Patients with Intracranial Hemorrhage. In Acute Stroke: Principles of Modern Management, American Academy of Neurology, March 2002, Baltimore, MD

Grand Rounds, Medical College of Wisconsin, Department of Neurology, Milwaukee, “Brain Arrest Neurologic Outcome Scale (BrANOS): predicting mortality following cardiac arrest:, January 25, 2002 A Review of Cerebral Blood Flow Physiology and Measurements Techniques. In 6PC.002, “ A Practical Guide to Blood Pressure Management in Neurologic Patients”, 55th Annual Meeting of the American Academy of Neurology, March 29-April 5, 2003, Honolulu, Hawaii.

Cerebral Venous Flow Anatomical and Physiological Perspectives. In 7DS.006, “ The Diagnosis and Management of Dural Sinus and Cerebral Venous Thrombosis”, 55th Annual Meeting of the American Academy of Neurology, March 29-April 5, 2003, Honolulu, Hawaii.

Acute Intracranial Hypertension and Cerebral Herniation Syndromes. In 7AC.001, “ Disorders of Intracranial Pressure for the Neurologists: The High, Low and Normal ICP”, 55th Annual Meeting of the American Academy of Neurology, March 29-April 5, 2003, Honolulu, Hawaii.

Grand Rounds, Sheboygan Hospital, Sheboygan “Current Concept in Stroke Management”, October 6, 2003 Grand Rounds, Medical College of Wisconsin, Department of Neurosurgery, Milwaukee, “ Update on Treatment of Cerebral Edema”, November 14, 2003 Grand Rounds, Medical College of Wisconsin, Department of Anesthesia and Critical Care Medicine, Milwaukee, “Neurointensive Care issues: Management of Head Injury”, November 18, 2003 EMS perceptorship Course, “Update in Stroke Management: Every Minutes Counts”, Medical College of Wisconsin, Milwaukee, January 22, 2004

Page 38: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

38

Blood Pressure in Acute Ischemic Stroke”. In 5PC.003, “ A Practical Guide to Blood Pressure Management in Neurologic Patients”, 56th Annual Meeting of the American Academy of Neurology, April 24 – May 1, 2004, San Francisco, California.

Cerebral Venous Thrombosis: A Guide to Clinical Diagnosis. In 2DS.004, “ The Diagnosis and Management of Dural Sinus and Cerebral Venous Thrombosis”, 56th Annual Meeting of the American Academy of Neurology, April 24 – May 1, 2004, San Francisco, California.

Acute Intracranial Hypertension and Cerebral Herniation Syndromes. In 6PC.004, “ Disorders of Intracranial Pressure for the Neurologists: The High, Low and Normal ICP”, 56th Annual Meeting of the American Academy of Neurology, April 24 – May 1, 2004, San Francisco, California. Grand Rounds, St. Mary Hospital, Milwaukee, “Current Concept in Stroke Management”, January 6, 2004.

Grand Rounds, St. Agnes Hospital, Fond Du Lac, Wisconsin, “Update on Acute Stroke Management”, June 17, 2004. A Guide to Medical and Endovascular Therapy of Patent Foramen Ovale. In “Patent Foramen Ovale and Cryptogenic Stroke”, 28th Annual Meeting of the American Society of Neuroimaging, March 3 – 6, 2005, Orlando, Florida. Accuracy of TCD in PFO Detection”. In “Patent Foramen Ovale and Cryptogenic Stroke, 28th Annual Meeting of the American Society of Neuroimaging, March 3 – 6, 2005, Orlando, Florida. Blood Pressure in Acute Ischemic Stroke. In 5PC.004, “A Practical Guide to Blood Pressure Management in Neurologic Patients”, 57th Annual Meeting of the American Academy of Neurology, April 9 – 16, 2005, Miami Beach, Florida. Cerebral Venous Thrombosis: A Guide to Clinical Diagnosis. In 2DS.004, “The Diagnosis and Management of Dural Sinus and Cerebral Venous Thrombosis”, 57th Annual Meeting of the American Academy of Neurology, April 9 – 16, 2005, Miami Beach, Florida. “Acute Intracranial Hypertension and Cerebral Herniation Syndromes”. In 8AC.006, “Disorders of Intracranial Pressure for the Neurologists: The High, Low and Normal ICP”, 57th Annual Meeting of the American Academy of Neurology, April 9 – 16, 2005, Miami Beach, Florida.

“Prevention and Treatment of Perioperative Stroke”. In 8BS.003, “Perioperative Stroke: A Practical Approach to Risk Stratification and Modification During the Preoperative Evaluation”, 57th Annual Meeting of the American Academy of Neurology, April 9 – 16, 2005, Miami Beach, Florida.

Grand Rounds, Columbia Hospital, Milwaukee, Wisconsin, “Update on Acute Stroke Management”, February 17, 2005 “Get with the Guidelines- The Science behind the Program”. Get with the Guidelines Stroke Workshop. American Heart Association, December 2005, Milwaukee, WI “Lupus and Neurological Involvement”. Presentation at the Lupus Foundation Meeting, November 2005, Milwaukee WI

Page 39: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

39

“TCD and PFO detection: Guide to Medical and Endovascular Therapy”. In “Clinical Implications of Emboli Monitoring”, 29th Annual Meeting of the American Society of Neuroimaging, March 2-5, 2006, San Diego, California. “Cerebral Venous Thrombosis: A Guide to Clinical Diagnosis”. In 8BS.006, “The Diagnosis and Management of Dural Sinus and Cerebral Venous Thrombosis”, 58th Annual Meeting of the American Academy of Neurology, April 1 – 8, 2006, San Diego, California. “Prevention and Treatment of Perioperative Stroke “. In 2BS.007, “Perioperative Stroke: A Practical Approach to Risk Stratification and Modification During the Preoperative Evaluation”, 58th Annual Meeting of the American Academy of Neurology, April 1 – 8, 2006, San Diego, California.

“The State of the State”. Presentation at the AHA Hospital Leadership Dinner, American Heart Association, March 2006, Kenosha, WI Grand Rounds, University of Nebraska, Department of Neurology, Omaha, Nebraska “Acute Stroke in 2006”, April 13, 2006 Noon Conference, University of Nebraska, Department of Neurology, Omaha, Nebraska “The Brain Code”, April 13, 2006 “Embolic Stroke: Pathogenesis, Diagnosis and Treatment”. In “Cardiac Stroke Symposium, September 30, 2006. Closing Plenary: "Managing Stroke in the ICU". Nurses Regional Meeting: "Continuity of Care: Closing the Gaps". National Stroke Association, September 12, 2006, Boston, Massachusetts.

Closing Plenary: "Managing Stroke in the ICU". Nurses Regional Meeting: Continuity of Care: Closing the Gaps". National Stroke Association, October 24, 2006, Orlando, Florida.

Plenary: Acute Stroke: "Hemorrhagic Stroke Emerging Treatments". Stroke Team Regional Meeting: Continuity of Care: Closing the Gaps". National Stroke Association, October 24, 2006, Orlando, Florida.

Closing Plenary: "Managing Stroke in the ICU". Nurses Regional Meeting: Continuity of Care: Closing the Gaps". National Stroke Association, December 5-7, 2006, Chicago, Illinois. Plenary: Acute Stroke: "Hemorrhagic Stroke Emerging Treatments". Stroke Team Regional Meeting: Continuity of Care: Closing the Gaps". National Stroke Association, December 5-7, 2006, Chicago, Illinois.

Grand Rounds, Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, “Update on Acute Stroke”, April 21, 2006

Grand Rounds, Medical College of Wisconsin, Department of Neurosurgery, Milwaukee, “Update: Intracerebral Hemorrhage”, December 08, 2006 “Cerebral Venous Thrombosis: A Guide to Clinical Diagnosis”. In “Dural Sinus and Cerebral Venous Thrombosis: Comprehensive Guide to Diagnosis and Management”, 30th Annual Meeting of the American Society of Neuroimaging, January 18 -21, 2007, Miami, Florida.

Page 40: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

40

“Prevention and Treatment of Perioperative Stroke “. In 8BS.001, “Perioperative Stroke: A Practical Approach to Risk Stratification and Modification During the Preoperative Evaluation”, 59th Annual Meeting of the American Academy of Neurology, April 28 – May 5, 2007, Boston, Massachusetts.

“ The Role of the NeuroICU: An Essential Piece of the Puzzolet”. Optimizing Stroke Service-Line Management, June 21-22, 2007, Arlington, Virginia. Keynote Address: “ How to Advance Your Stroke Program When There Are No Advances in Stroke Treatment”. Midwest Regional Meeting. National Stroke Association, October 14-16, 2007, St. Louis, Missouri.

Plenary: “ Stroke in the Emergency Room”. Midwest Regional Meeting. National Stroke Association, October 14-16, 2007, St. Louis, Missouri. “Treatment of Hypertensive Emergencies in Surgery, ICH, and Stroke”. Grand Rounds, United Hospital System, January, 2007, Kenosha, Wisconsin. Hospital

“Medical Management of ICH”. In “iTEAM ICH Critical Pathways Hospital Program”, January 26, 2007, Milwaukee, WI Grand Rounds, Medical College of Wisconsin, Department of Physical Medicine and Rehabilitation, Milwaukee, “Role of Dopamine Receptors Modulation in Neuroprotection following Global Ischemia”, September 13, 2007 “ICH Critical Pathways: Rationale, Development, and Implementation”. In “iTEAM ICH Critical Pathways Hospital Program”, January 26, 2007, Milwaukee, WI Grand Rounds, “Intracerebral Hemorrhage: Time for Action”, University of Massachusetts Medical School, Department of Neurology, Worcester, MA, June 5, 2007.

Grand Rounds, “Hypertensive Emergencies in Intracerebral Hemorrhage: Pathophsyiology and Management”, Sacred Heart Hospital, Spokane, WA, September 14, 2007. “Prevention and Treatment of Perioperative Stroke “. In 3BS.005, “Perioperative Stroke: A Practical Approach to Risk Stratification and Modification During the Preoperative Evaluation”, 60th Annual Meeting of the American Academy of Neurology, April 12-19, 2008, Chicago, Illinois.

“ Stroke Case Review”, Sacred Heart Hospital, Eau Claire, WI, April 3rd , 2008. “ Neuroprotective Therapeutic Hypothermia”, Neenah Medical Centerl, Neenah, WI, June 11, 2008. Grand Rounds, Medical College of Wisconsin, Department of Neurosurgery, Milwaukee, “Hypothermia in the NICU: Are We There Yet”, April 13, 2008

Grand Rounds, Medical College of Wisconsin, Cardiology Division, Department of Internal Medicine, Milwaukee, “Hypothermia: Is it Ready for Prime Time”, May 5th, 2008 Plenary: “ The Future of Neurocritical Care Training: A Multidisciplinary Summit”, 7th Annual Neurocritical Care Meeting, November 11-14, 2009, New Orleans, Louisiana.

“What’s New in the Management of Intracranial Hypertension“. In 7FC.004, “Neurologic Intensive Care”, 62th Annual Meeting of the American Academy of Neurology, April 10-17, 2010, Toronto, Canada

Page 41: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

41

“Prediction of Outcome in Survivors of Cardiopulmonary Resuscitation: Evidence-Based Approach“. In 8BS.005, “Advances in the Care of Brain Injury After Resuscitation from Cardiac Arrest”, 62th Annual Meeting of the American Academy of Neurology, April 10 - 17, 2010, Toronto, Canada

Grand Rounds, Medical College of Wisconsin, PM&R Department, Milwaukee, “Role of Progesterone in Traumatic Brain Injury”, June 4, 2010 Infrared Technology. Setting Standard in Research, 8th Annual Neurocritical Care Meeting, September 15-18, 2010, San Francisco, California. “CNS Infection in the ICU “. In 8AC.003, “Consultation in the Medical Surgical ICU”, 63th Annual Meeting of the American Academy of Neurology, April 9 - 16, 2011, Honolulu, HI “Initial Workup and Differential Diagnosis “. In 8ES.002, “Acute Encephalopathy”, 63th Annual Meeting of the American Academy of Neurology, April 9 - 16, 2011, Honolulu, HI Electrolytes and Acid-Base Disorders, 9th Annual Neurocritical Care Meeting, September 21-24, 2011, Montreal, Canada. “Developing Clinical Trials and ICU Management of ICH “. In 3FC.002, “Neurologic Intensive Care”, 64th Annual Meeting of the American Academy of Neurology, April 21-28, 2012, New Orleans, LA “Altered Consciousness and Delirium in the ICU “. In 1HC.005, “Consultation in the Medical Surgical ICU”, 64th Annual Meeting of the American Academy of Neurology, April 21-28, 2012, New Orleans, LA ANIM-NCS Joint Consensus Statement on Large Hemispheric Infarction, 10th Annual Neurocritical Care Meeting, October 4-7, 2012, Denver, Colorado. Running A Neuro ICU: The Essentials of Staffing, Equipment and Nursing Skills, Critical Care Congress, January 19-23, 2013, San Juan, PR

Hypoxic-Ischemic Coma and Reanimation: How and When Do You Know, Critical Care Congress, January 19-23, 2013, San Juan, PR Oncotic Approach to Cerebral edema. Critical Care Congress, January 19-23, 2013, San Juan, PR Joint Consensus Statement on Large Hemispheric Infarction, ANIM Annual Meeting, January 23-26, 2013, Mannheim, Germany. “Altered Consciousness and Delirium in the ICU “. In 1HC.005, “Consultation in the Medical Surgical ICU”, 65th Annual Meeting of the American Academy of Neurology, March 16-23, 2013, San Diego, CA “Traumatic Brain Injury “. In 3FC.002, “Neurologic Intensive Care”, 65th Annual Meeting of the American Academy of Neurology, March 16-23, 2013 San Diego, CA The Confused Guy Sitting in the Corner, Case-Based Pearls in Neurocritical Care, Critical Care Congress, January 9-13, 2014, San Francisco, CA Oncotic Approach to Cerebral Edema, Critical Care Congress, January 9-13, 2014, San Francisco, CA

Page 42: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

42

“Altered Consciousness and Delirium in the ICU “. In C.120, “Consultation in the Medical Surgical ICU”, 64th Annual Meeting of the American Academy of Neurology, April 26 – May 4, 2014, Philadelphia, PA Visiting Professor, Grand Rounds, American Lebanese University, Department of Neurology, Risk Hospital, Beirut, Lebanon “Update on Acute Stroke Management”, July 31, 2014. “Guidelines for the Management of Severe Ischemic Stroke”. Neurocritical Care Society, 12th Annual Meeting, September 11-14, 2014, Seattle, WA “ Challenges and Success of Telestroke Program in Treatment of Acute CVA, 6th Annual Cardiovascular Emergency Conference, Columbus, OH, September 17, 2014 “Altered Consciousness and Delirium in the ICU “. In C.120, “Consultation in the Medical Surgical ICU”, 64th Annual Meeting of the American Academy of Neurology, April 18-25, 2015, Washington, DC

COURSE AND SYMPOSIUM CHAIR

Course Director, A Practicum in Transcranial Doppler Ultrasound, Johns Hopkins University, School of Medicine, December 2-6, 2002, Baltimore, MD Co-Chair, Cerebrovascular Disease Thrombolysis Session, at the 54th Annual Meeting of the American Academy of Neurology, April 13-20, 2002, Denver, CO Co-Chair, Cerebrovascular Disease Basic Science-Genetics Scientific Session, at the 55th Annual Meeting of the American Academy of Neurology, March 29-April 5, 2003, Honolulu, Hawaii Course Director, A Practicum in Transcranial Doppler Ultrasound, Johns Hopkins University, School of Medicine, March 17-21, 2003, Baltimore, MD Course Director, 6PC.002, “ A Practical Guide to Blood Pressure Management in Neurologic Patients”, 55th Annual Meeting of the American Academy of Neurology, March 29-April 5, 2003, Honolulu, Hawaii. Course Director, 7DS.006, “ The Diagnosis and Management of Dural Sinus and Cerebral Venous Thrombosis”, 55th Annual Meeting of the American Academy of Neurology, March 29-April 5, 2003, Honolulu, Hawaii. Co-Chair, Cerebrovascular Disease: Imaging Scientific Session, at the 56th Annual Meeting of the American Academy of Neurology, April 24 – May 1, 2004, San Francisco, California. Course Director, 5PC.003, “ A Practical Guide to Blood Pressure Management in Neurologic Patients”, 56th Annual Meeting of the American Academy of Neurology, April 24 – May 1, 2004, San Francisco, California. Course Director, 2DS.004, “ The Diagnosis and Management of Dural Sinus and Cerebral Venous Thrombosis”, 56th Annual Meeting of the American Academy of Neurology, April 24 – May 1, 2004, San Francisco, California.

Page 43: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

43

Co-Chair, Cerebrovascular Disease: Stroke Recovery and Basic Science Scientific Session, 57th Annual Meeting of the American Academy of Neurology, April 9 – 16, 2005, Miami Beach, Florida. Course Director, 5PC.004, “ A Practical Guide to Blood Pressure Management in Neurologic Patients”, 57th Annual Meeting of the American Academy of Neurology, April 9 – 16, 2005, Miami Beach, Florida. Course Director, 2DS.004, “The Diagnosis and Management of Dural Sinus and Cerebral Venous Thrombosis”, 57th Annual Meeting of the American Academy of Neurology, April 9 – 16, 2005, Miami Beach, Florida. Course Director, “Patent Foramen Ovale and Cryptogenic Stroke”, 28th Annual Meeting of the American Society of Neuroimaging, March 3 – 6, 2005, Orlando, Florida. Course Director, 8BS.006, “The Diagnosis and Management of Dural Sinus and Cerebral Venous Thrombosis”, 58th Annual Meeting of the American Academy of Neurology, April 1 – 8, 2006, San Diego, California. Symposium Co-Director, “Cardiac Stroke Symposium”, September 30, 2006, Milwaukee, WI Program Chair, “iTEAM ICH Critical Pathways Hospital Program, January 26, 2007, Milwaukee, WI Course Director, “Dural Sinus and Cerebral Venous Thrombosis: Comprehensive Guide to Diagnosis and Management”, 30th Annual Meeting of the American Society of Neuroimaging, January 18 -21, 2007, Miami, Florida. Chair, Plenary Session: The Lung Bone’s Connected to the Brain Bone: Brain-Lung Interactions., 7th Annual Neurocritical Care Meeting, November 11-14, 2009, New Orleans, Louisiana Co-Chair, Stroke/Endovascular/Critical Care Highlights in the Field Session, 62th Annual Meeting of the American Academy of Neurology, April 10 - 17, 2010, Toronto, Canada Co-Chair, Translational Science in Neurocritical Care Symposium: Almost Ready for Bedside, 8th Annual Neurocritical Care Meeting, September 15-18, 2010, San Francisco California. Course Director, 8ES.002, “Acute Encephalopathy”, 64th Annual Meeting of the American Academy of Neurology, April 21-28, 2012, New Orleans, LA. Chair, Developing a Research Program in the Current Economic Era, Critical Care Congress, January 19-23, 2013, San Juan, PR. Chair, Management of Cerebral Edema, Critical Care Congress, January 19-23, 2013, San Juan, PR Chair, Management of Cerebral Edema, Critical Care Congress, January 9-13, 2014, San Francisco, CA

PEER REVIEWED EDUCATIONAL PRODUCTS:

SYLLABI FOR AMERICAN ACADEMY OF NEUROLOGY

Page 44: Torbey UNM CV 10.2 UNM CV 10_2_19 (1).pdf · 07/2006 – 06/2009 Associate Director, Neurosciences Service Line, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 07/2006 – 12/2010

Michel T Torbey, MD, MPH, FAHA, FCCM, FNCS, FANA October 2, 2019

44

Editor - 6PC.002, “A Practical Guide to Blood Pressure Management in Neurologic Patients”, Course syllabus for the Scientific Meeting of the 55th Annual Meeting of the American Academy of Neurology, March 29-April 5, 2003, Honolulu, Hawaii.

Editor - 7DS.006, “ The Diagnosis and Management of Dural Sinus and Cerebral Venous Thrombosis”, Course syllabus for the Scientific Meeting of the 55th Annual Meeting of the American Academy of Neurology, March 29-April 5, 2003, Honolulu, Hawaii.

Editor - 5PC.003, “A Practical Guide to Blood Pressure Management in Neurologic Patients”, Course syllabus for the Scientific Meeting of the 56th Annual Meeting of the American Academy of Neurology, April 24 – May 1, 2004, San Francisco, California.

Editor - 2DS.004, “ The Diagnosis and Management of Dural Sinus and Cerebral Venous Thrombosis”, Course syllabus for the Scientific Meeting of the 56th Annual Meeting of the American Academy of Neurology, April 24 – May 1, 2004, San Francisco, California.

Editor - 5PC.004, “A Practical Guide to Blood Pressure Management in Neurologic Patients”, Course syllabus for the Scientific Meeting of the 57th Annual Meeting of the American Academy of Neurology, April 9 – 16, 2005, Miami Beach, Florida.

Editor - 2DS.004, “The Diagnosis and Management of Dural Sinus and Cerebral Venous Thrombosis”, Course syllabus for the Scientific Meeting of the 57th Annual Meeting of the American Academy of Neurology, April 9 – 16, 2005, Miami Beach, Florida.

Editor - “Patent Foramen Ovale and Cryptogenic Stroke”, Course syllabus for the 28th Annual Meeting of the American Society of Neuroimaging, March 3 – 6, 2005, Orlando, Florida.

Editor - 8BS.006, “The Diagnosis and Management of Dural Sinus and Cerebral Venous Thrombosis”, Course syllabus for the Scientific Meeting of the 58th Annual Meeting of the American Academy of Neurology, April 1 – 8, 2006, San Diego, California.